<?xml version="1.0" encoding="UTF-8"?> <rss
version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
><channel><title>Life in the Fast Lane Medical Blog &#187; lecture notes</title> <atom:link href="http://lifeinthefastlane.com/education/lecture-notes/feed/" rel="self" type="application/rss+xml" /><link>http://lifeinthefastlane.com</link> <description>Emergency Medicine education blog</description> <lastBuildDate>Thu, 24 May 2012 10:28:35 +0000</lastBuildDate> <language>en</language> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <generator>http://wordpress.org/?v=3.3.2</generator> <item><title>Mediterranean Emergency Medicine Congress &#8211; VI &#8211; Podcasts</title><link>http://lifeinthefastlane.com/2011/12/memc-vi/</link> <comments>http://lifeinthefastlane.com/2011/12/memc-vi/#comments</comments> <pubDate>Sat, 31 Dec 2011 04:58:35 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[Conference]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[eLearning]]></category> <category><![CDATA[Emergency Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Podcast]]></category> <category><![CDATA[Emergency Medicine Congress]]></category> <category><![CDATA[free podcast]]></category> <category><![CDATA[joe lex]]></category> <category><![CDATA[Mediterranean Emergency Medicine Congress]]></category> <category><![CDATA[MEMC-VI]]></category> <category><![CDATA[podcast]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=48593</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2011/12/memc-vi/">Mediterranean Emergency Medicine Congress &#8211; VI &#8211; Podcasts</a></p><p>More than 100 podcast talks from the Mediterranean Emergency Medicine Congress 2011 thanks to the inimitable Joe Lex</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2011/12/memc-vi/">Mediterranean Emergency Medicine Congress &#8211; VI &#8211; Podcasts</a></p><p
align="center"><strong>Kos Greece – 12 – 14 September 2011</strong></p><blockquote><p>Joe Lex has just uploaded more than 170 free MP3 podcasts of talks from <a
href="http://www.emcongress.org/2011/" target="_blank">MEMC-VI</a> on Kos Greece, from September 12-14 2011.  You can either search directly for talks on <a
href="http://freeemergencytalks.net/?tag=memc-vi-kos-2011" target="_blank">Free Emergency Talks</a>, visit the <a
href="http://www.youtube.com/user/MEMC2011" target="_blank">YouTube channel</a>, use the catalogue of links below to access them or wait for them to be entered into the <a
href="http://lifeinthefastlane.com/resources/podcasts/">LITFL podcast database</a>&#8230;enjoy</p></blockquote><h4><strong>Day 1, Plenary</strong></h4><ul><li>Patrick Croskerry (Canada): <a
href="http://freeemergencytalks.net/?p=6361">Diagnostic Error – A Case of Neglect </a><strong></strong></li><li>Ziad Kazzi (Georgia): <a
href="http://freeemergencytalks.net/?p=6364">The Public Health Impacts of a Nuclear Plant Crisis in Your Backyard</a><strong></strong></li></ul><h4><strong>Day 1: Resuscitation</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6343">Marc Sabbe (Belgium): ILCOR 2010 Guidelines &#8211; Implementation in Different Environments</a></li><li><a
href="http://freeemergencytalks.net/?p=6346">Deborah Diercks (California): Updates from the International Committee on Resuscitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6349">Scott Weiner (Massachusetts): Update on Prehospital Airway and Resuscitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6352">Scott Silvers (Florida): The New ACLS Guidelines</a></li><li><a
href="http://freeemergencytalks.net/?p=6355">Marvin Wayne (Washington): Therapeutic Hypothermia Post Cardiac Arrest</a></li><li><a
href="http://freeemergencytalks.net/?p=6358">Marcus Ong (Singapore): Autopulse Mechanical CPR Device for Out-of-Hospital Cardiac Arrest</a></li></ul><h4><strong>Day 1: Shock &amp; Sepsis</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6367">Vu Kiet Tran (Canada): Non-Invasive Tools for the Diagnosis and Monitoring of Shock/Sepsis in the Emergency Department</a></li><li><a
href="http://freeemergencytalks.net/?p=6370">David A. Talan (California): Procalcitonin &#8211; How Useful Is It in the ED?</a></li><li><a
href="http://freeemergencytalks.net/?p=6373">Christoph Dodt (Germany): The Importance of the Autonomic Nervous System in Early Sepsis</a></li><li><a
href="http://freeemergencytalks.net/?p=6376">Abdel Bellou (France): Biomarkers in Sepsis &#8211; Are They Useful?</a></li><li><a
href="http://freeemergencytalks.net/?p=6379">Alan Jones (Mississippi): Lactate in Emergency Department Shock &#8211; What Does It Mean and How Do I Use It?</a></li><li><a
href="http://freeemergencytalks.net/?p=6387">Fernando Schiraldi (Italy): Full or Empty &#8211; Diagnostic Challenges for the Patient in Shock</a></li></ul><h4><strong>Day 1: Toxicology &amp; Pharmacology</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6392">Kurt Anseeuw (Belgium): Cyanide Poisoning by Fire Smoke Inhalation &#8211; An Algorithm of Treatment</a></li><li><a
href="http://freeemergencytalks.net/?p=6395">Melanie Stander (South Africa): The Management of Ethylene Glycol Poisoning</a></li><li><a
href="http://freeemergencytalks.net/?p=6398">David M. Wood (United Kingdom): Novel Psychoactive Substances &#8211; Recreational Drug Toxicity</a></li><li><a
href="http://freeemergencytalks.net/?p=6401">Judd E. Hollander (Pennsylvania): Update on Cocaine Myocardial Ischemia</a></li><li><a
href="http://freeemergencytalks.net/?p=6404">Dianne P. Calello (New Jersey): Cyanide Toxicity &#8211; Cyanide Antidote Kit vs. Cyanocobalamin</a></li><li><a
href="http://freeemergencytalks.net/?p=6407">Francisco Moya Torrecilla (Spain): New Anticoagulants in the Management of Acute Entities Like Atrial Fibrillation</a></li></ul><h4><strong>Day 1: Medical Imaging</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6412">Hein Lamprecht (South Africa): The FASH (Focused Assessment of Sonography in HIV-TB) Scan</a></li><li><a
href="http://freeemergencytalks.net/?p=6415">Robert Jarman (United Kingdom): Lung Point of Care Ultrasound Scans</a></li><li><a
href="http://freeemergencytalks.net/?p=6418">Michael Drescher (Connecticut): The Role of CT Angiography in the Diagnosis of Subarachnoid Hemorrhage</a></li><li><a
href="http://freeemergencytalks.net/?p=6423">Francisco Moya Torrecilla (Spain): CT for Management of Chest Pain</a></li><li><a
href="http://freeemergencytalks.net/?p=6426">Gregory Garra (New York): Ultrasound for Assessing an Ectopic Pregnancy &#8211; Pros and Cons of the Discriminatory Zone</a></li><li><a
href="http://freeemergencytalks.net/?p=6429">Jeffrey M. Freeman (Michigan): Ultrasound Imaging to Assess Increased Intracranial Pressure</a></li></ul><h4><strong>Day 1: History of Emergency Medicine</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6434">David Williams (United Kingdom): The Development of European Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6437">Robert E. Suter (Texas): Hippocrates &#8211; Father of 19th Century of American Reformation in Medicine?</a></li><li><a
href="http://freeemergencytalks.net/?p=6440">Helen Askitopoulou (Greece): Emergencies &amp; Acute Diseases in the Hippocratic Corpus</a></li><li><a
href="http://freeemergencytalks.net/?p=6443">Joe Lex (Pennsylvania): A Shocking History of Electroresuscitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6446">Terry Kowalenko (Michigan): Presidential Assassinations &#8211; The Medical History</a></li><li><a
href="http://freeemergencytalks.net/?p=6449">Venkataraman Anantharaman (Singapore): From 3rd World to 1st World &#8211; Evolving an Asian Brand of Emergency Medicine</a></li></ul><h4><strong>Day 1: Administration</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6453">Mark Reiter (Pennsylvania): The &#8220;No Waiting Room&#8221; ED</a></li><li><a
href="http://freeemergencytalks.net/?p=6456">Darren Kilroy (United Kingdom): The Effective Clinical Engagement of the Emergency Department Team</a></li><li><a
href="http://freeemergencytalks.net/?p=6459">Matthias Brachmann (Germany): Key Performance Indicators for an Emergency Department</a></li><li><a
href="http://freeemergencytalks.net/?p=6462">Richard Wolfe (Massachusetts): Learning to Be a Department Chair &#8211; The Responsibilities of Leadership</a></li><li><a
href="http://freeemergencytalks.net/?p=6465">Howard Blumstein (North Carolina): Emergency Department Patient Safety Initiatives</a></li><li><a
href="http://freeemergencytalks.net/?p=6469">Barbara Hogan (Germany): Emergency Department Design Meets Lean Management</a></li></ul><h4><strong>Day 1: Research in Emergency Medicine</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6473">Gary Gaddis (Kansas): How to Start Emergency Medical Research</a></li><li><a
href="http://freeemergencytalks.net/?p=6476">Abdel Bellou (France): Evaluation of Research in Emergency Medicine in Europe</a></li><li><a
href="http://freeemergencytalks.net/?p=6479">Sean Gottschalk (South Africa): Knowledge Translation &#8211; Clinical Decision Rules</a></li><li><a
href="http://freeemergencytalks.net/?p=6482">Paul Barach (Australia): Assessing and Improving Team Performance in Acute Care Settings</a></li><li><a
href="http://freeemergencytalks.net/?p=6485">Leslie Zun (Illinois): Pitfalls of Emergency Department Research in the Area of Psychiatric Emergencies</a></li><li><a
href="http://freeemergencytalks.net/?p=6488">David A. Talan (California): Emergency Department-Based National Sentinel Network for Research on Emerging Infectious Disease</a></li><li><a
href="http://freeemergencytalks.net/?p=6491">Said Laribi (France): Networking in Research in Emergency Medicine &#8211; Description of a Great Network</a></li><li><a
href="http://freeemergencytalks.net/?p=6494">David Taylor (Australia): Research Ethics and Governance for Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6497">Nicola Parenti (Italy): A Review on Clinical Governance in Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6500">Robert E. O&#8217;Connor (Virginia): Research Director on a Low Budget</a></li><li><a
href="http://freeemergencytalks.net/?p=6503">Carlos Garcia Rosas (Mexico): Methods of Evaluation in the Emergency Room &#8211; MEXICO vs Mexican Official Rule</a></li><li><a
href="http://freeemergencytalks.net/?p=6506">Maaret Castren (Sweden): CPR and Cooling in Cardiac Arrest</a></li></ul><div><h4><strong>Day 2: Plenary</strong></h4></div><ul><li><a
href="http://freeemergencytalks.net/?p=6533">Pierre Carli (France): Trends in Prehospital Emergency Care in Europe</a></li><li><a
href="http://freeemergencytalks.net/?p=6536">Mark Leong (Singapore): Promoting Emergency Medicine Through Education</a></li></ul><h4><strong>Day 2: Cardiovascular Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6512">Phillip D. Levy (Michigan): Phenotype-Driven Management of Acute Heart Failure &#8211; An Emerging Concept That&#8217;s Here to Stay</a></li><li><a
href="http://freeemergencytalks.net/?p=6515">Fernando Schiraldi (Italy): Arrhythmias Caused by Electrolyte Disorders</a></li><li><a
href="http://freeemergencytalks.net/?p=6518">Said Laribi (France): Epidemiology of Acute Heart Failure</a></li><li><a
href="http://freeemergencytalks.net/?p=6521">Franck Verschuren (Belgium): Organ Donation after Cardiac Death &#8211; </a></li><li><a
href="http://freeemergencytalks.net/?p=6524">Mark Langdorf (California): Diagnosis of ACS in the Presence of Bundle Branch Blocks and Pacemakers</a></li><li><a
href="http://freeemergencytalks.net/?p=6527">Swee Han Lim (Singapore): Calcium Channel Blockers &#8211; Most Cost Effective for Supraventricular Tachycardias &amp; Atrial Fibrillation</a></li></ul><h4><strong>Day 2: Paediatric Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6539">Santiago Mintegi Raso (Spain): New Challenges in the Management of Very Young Febrile Infants</a></li><li><a
href="http://freeemergencytalks.net/?p=6542">Kee-Chong Ng (Singapore): Preparing the Children&#8217;s Emergency Department for Viral Epidemics</a></li><li><a
href="http://freeemergencytalks.net/?p=6545">Gregory Garra (New York): Acute Phase Reactant Testing for Predicting Occult Bacteremia</a></li><li><a
href="http://freeemergencytalks.net/?p=6548">Indrani Sheridan (Saipan): Delivering Bad News When the Patient Is a Child</a></li><li><a
href="http://freeemergencytalks.net/?p=6551">Itai Shavit (Israel): Propofol Sedation in Paediatric Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6554">Arif Tyebally (Singapore): Role of Children&#8217;s Emergency Department in Childhood Injury Prevention</a></li></ul><h4><strong>Day 2: Disaster and Mass Casualty</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6561">Efstratios Photiou (Italy): Risk Communication in Recent Disasters &#8211; How Did It Work? How Should It Work?</a></li><li><a
href="http://freeemergencytalks.net/?p=6564">Mark Leong (Singapore): Mass Casualty Decontamination in the Emergency Department</a></li><li><a
href="http://freeemergencytalks.net/?p=6567">Herman Delooz (Belgium): Disaster Bioethics &#8211; Taking Care of the Carers</a></li><li><a
href="http://freeemergencytalks.net/?p=6570">Ioannis Galatas (Greece): Are Hospitals Prepared to Deal with New Emerging Threats?</a></li><li><a
href="http://freeemergencytalks.net/?p=6574">Kristi Koenig (California): Public Health Policy in Disaster Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6530">Elizabeth Devos (Florida): Psychological Issues in Disaster</a></li></ul><h4><strong>Day 2: Prehospital Medicine</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6578">Maaret Castren (Sweden): Identification of Sepsis &#8211; Is It Possible in the Prehospital Setting?</a></li><li><a
href="http://freeemergencytalks.net/?p=6581">Stephen C. Morris (Washington): Assessing Emergency Medical Systems in Low Income Countries</a></li><li><a
href="http://freeemergencytalks.net/?p=6584">Patrick Plaisance (France): Is Noninvasive Ventilation Beneficial in the Prehospital Setting?</a></li><li><a
href="http://freeemergencytalks.net/?p=6587">Brian Walsh (New Jersey): Should Prehospital Intubation Be Deferred?</a></li><li><a
href="http://freeemergencytalks.net/?p=6590">Raed Arafat (Romania): The Concept of Integrated Mobile Command and Control Center in the Management of Mass Casualty Incidents</a></li><li><a
href="http://freeemergencytalks.net/?p=6593">Brian Walsh (New Jersey): Prehospital Medications &#8211; How Well Do They Store?</a></li></ul><h4><strong>Day 2: Abdominal Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6597">Roberta Petrino (Italy): Do &#8220;Belly Labs&#8221; Ever Help?</a></li><li><a
href="http://freeemergencytalks.net/?p=6600">Kevin Rodgers (Indiana): Evidence-Based Approach to Ischemic Bowel Disease</a></li><li><a
href="http://freeemergencytalks.net/?p=6603">Kevin Reed (Maryland): Key Features in Abdominal Aortic Aneurysm Care</a></li><li><a
href="http://freeemergencytalks.net/?p=6606">David Brown (Ohio): The Differential Diagnosis of Acute Flank Pain</a></li><li><a
href="http://freeemergencytalks.net/?p=6609">Nikolas Sbyrakis (Greece): When Abdominal Pain Does Not Mean Abdominal Emergency</a></li><li><a
href="http://freeemergencytalks.net/?p=6612">Christian Wrede (Germany): Undifferentiated Abdominal Pain &#8211; What To Do?</a></li></ul><h4><strong>Day 2: Pulmonary Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6615">Frederic Thys (Belgium): Noninvasive Ventilation in the Prehospital Setting</a></li><li><a
href="http://freeemergencytalks.net/?p=6618">Arian Nachat (California): Alternative Medicine in the Treatment of Asthma</a></li><li><a
href="http://freeemergencytalks.net/?p=6621">Franck Verschuren (Belgium): Management of Pulmonary Embolism &#8211; ICU/CCU, General Ward, or Home?</a></li><li><a
href="http://freeemergencytalks.net/?p=6624">Christoph Dodt (Germany): Noninvasive Ventilation in Acute Respiratory Failure in the Emergency Department</a></li><li><a
href="http://freeemergencytalks.net/?p=6627">Robert McNamara (Pennsylvania): Additional Agents for Acute Asthma</a></li><li><a
href="http://freeemergencytalks.net/?p=6630">Paolo Groff (Italy): Undifferentiated Dyspnea &#8211; Emergency Approach and Management</a></li></ul><h4><strong>Day 2: Administration</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6634">George W. Molzen (New Mexico): Quality Indicators in Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6637">Paul Porter (Rhode Island): The Administrative Role in the Difficult Emergency Department Patient</a></li><li><a
href="http://freeemergencytalks.net/?p=6640">Ruth Brown (United Kingdom): The Management and Organisational Issues of Integration of Residents in the Emergency Department Staff</a></li><li><a
href="http://freeemergencytalks.net/?p=6643">Jeffrey Arnold (California): Taking the &#8216;Dys&#8217; Out of Dysfunctional &#8211; Lessons Learned from Turning Around Troubled Emergency Departments</a></li><li><a
href="http://freeemergencytalks.net/?p=6646">Anne Fontanel (France): Added Value of Point-of-Care in Emergency Departments</a></li><li><a
href="http://freeemergencytalks.net/?p=6649">Colin A. Graham (Hong Kong): Academic Excellence in Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6652">Paul Porter (Rhode Island): Choosing the Right Emergency Department Tracking System</a></li><li><a
href="http://freeemergencytalks.net/?p=6655">Raed Arafat (Romania): Telemedicine for Implementing the Hub and Spoke System</a></li><li><a
href="http://freeemergencytalks.net/?p=6658">Seung Pil Choi (Korea): Implementing Hospital Side Changes in Dealing with Post-Cardiac Arrest Syndrome</a></li><li><a
href="http://freeemergencytalks.net/?p=6661">Gautam Bodiwala (United Kingdom): Establishing Emergency Medicine as a Specialty</a></li><li><a
href="http://freeemergencytalks.net/?p=6664">William T. Durkin Jr.: Impact of LEAN Techniques on Emergency Medicine Management</a></li><li><a
href="http://freeemergencytalks.net/?p=6667">David Thorisson (Sweden): Information Technology in Emergency Medicine</a></li></ul><h4><strong>Day 2: Medical Education</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6671">Terry Kowalenko (Michigan): The Impaired Physician &#8211; Substance Abuse in Residency</a></li><li><a
href="http://freeemergencytalks.net/?p=6674">Venkataraman Anantharaman (Singapore): Assessment Tools in Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6677">Taj Hassan (United Kingdom): Opportunities, Challenges and Solutions for a Web-Based Emergency Medicine Training Platform &#8211; ENLIGHTENme</a></li><li><a
href="http://freeemergencytalks.net/?p=6680">Helen Askitopoulou (Greece): The Diversity of Emergency Medicine Training in Europe</a></li><li><a
href="http://freeemergencytalks.net/?p=6683">Ruth Brown (United Kingdom): The UK Curriculum and Examination in Emergency Medicine &#8211; Evaluation of Method and Outcome</a></li><li><a
href="http://freeemergencytalks.net/?p=6686">Roberta Petrino (Italy): The Process for the European Board Exam in Emergency Medicine &#8211; Curriculum Applied to the Exam</a></li><li><a
href="http://freeemergencytalks.net/?p=6689">Michael Silverman (New Jersey): How Do You Make Sure Students Are Not Ignored by Emergency Medicine Faculty</a></li><li><a
href="http://freeemergencytalks.net/?p=6693">Eric Revue (France): How Students Differ from Residents</a></li><li><a
href="http://freeemergencytalks.net/?p=6697">Michael E. Silverman (New Jersey): Bedside Teaching</a></li><li><a
href="http://freeemergencytalks.net/?p=6700">Kum Ying Tham (Singapore): Hybridization of Emergency Medicine Training Programs</a></li><li><a
href="http://freeemergencytalks.net/?p=6703">Luan E. Lawson (North Carolina): Teaching Teams for the 21st Century</a></li><li><a
href="http://freeemergencytalks.net/?p=6707">Brad Bunney (Illinois): Use of Cadaver Lab in Emergency Medicine Resident Education</a></li></ul><h4><strong>Day 3: Plenary</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6730">Francesco Della Corte (Italy): Disaster Medicine &#8211; Moving Towards a New Academic Discipline</a></li><li><a
href="http://freeemergencytalks.net/?p=6733">Ed Sloan (Illinois): An Emergency Medicine Foundation &#8211; Joys, Pitfalls, and Lessons Learned</a></li></ul><h4><strong>Day 3: Trauma</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6711">Colin A. Graham (Hong Kong): Futility of Trauma Resuscitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6714">Joanne Williams (California): Permissive Hypotension in the Emergency Department &#8211; Pros &amp; Cons</a></li><li><a
href="http://freeemergencytalks.net/?p=6717">Raed Arafat (Rumania): Avoiding the Lethal Triad &#8211; Hypothermia, Coagulopathy, Acidosis</a></li><li><a
href="http://freeemergencytalks.net/?p=6721">Carlos Garcia Rosas (Mexico): The Trauma Impact in Mexico</a></li><li><a
href="http://freeemergencytalks.net/?p=6724">Kum Ying Tham (Singapore): As the World Ages &#8211; Geriatric Trauma Resuscitation in the Emergency Department</a></li><li><a
href="http://freeemergencytalks.net/?p=6727">Christopher Lee (New York): Emergency Department Thoracotomy Controversies</a></li></ul><h4><strong>Day 3: Neurologic Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6736">Frederick Fiesseler (New Jersey): Subarachnoid Headache &#8211; CT Angiography vs Lumbar Puncture</a></li><li><a
href="http://freeemergencytalks.net/?p=6739">Brad Bunney (Illinois): 3 Hour versus 4.5 Hour Window for CVA and TPA</a></li><li><a
href="http://freeemergencytalks.net/?p=6742">Luis Garcia Castrillo Riesco (Spain): Cephalea Alert Signals</a></li><li><a
href="http://freeemergencytalks.net/?p=6745">Juliusz Jakubaszko (Poland): Headache in the Emergency Department &#8211; Pitfalls and Treatments</a></li><li><a
href="http://freeemergencytalks.net/?p=6748">Edward P. Sloan (Illinois): Neuroresuscitative Skills Every Emergency Physician Should Know</a></li><li><a
href="http://freeemergencytalks.net/?p=6751">Andrew Asimos (North Carolina): ABC&#8217;s of Risk Stratification for TIA (ABCD, ABCD2, ABCD2I, ABCD3I) &#8211; Should We Be Using Any of These?</a></li></ul><h4><strong>Day 3: Psychobehavioral Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6755">Carl Blijd (Netherlands): Aggression Management &#8211; Theories, Myths, De-escalation, and Prevention</a></li><li><a
href="http://freeemergencytalks.net/?p=6758">Heather Prendergast (Illinois): Atypicals Are Better Than Typical Antipyschotics for Acute Agitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6761">Vu Kiet Tran (Canada): Treatment of Agitation</a></li><li><a
href="http://freeemergencytalks.net/?p=6764">Thomas Lukens (Ohio): Psychiatric Medical Clearance</a></li><li><a
href="http://freeemergencytalks.net/?p=6767">Nikolas Sbyrakis (Greece): Psychosocial Impact of Acute Illness &#8211; Injury on Emergency Department Patients &#8211; Time to Address the Problem</a></li><li><a
href="http://freeemergencytalks.net/?p=6771">Jana Seblova (Czech Republic): Crisis Intervention in the Emergency Department &#8211; Both for Patients and Personnel</a></li></ul><h4><strong>Day 3: Environmental and Wilderness Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6774">Polat Durukan (Turkey): Snake Bite Envenomations</a></li><li><a
href="http://freeemergencytalks.net/?p=6778">Sean Gottschalk (South Africa): Nepal Expedition Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6781">Jana Seblova (Czech Republic): Drowning and Hypothermia &#8211; An Update for the Emergency Physician</a></li><li><a
href="http://freeemergencytalks.net/?p=6784">Diane P. Calello (New Jersey): Radiation Antidotes &#8211; An Update</a></li><li><a
href="http://freeemergencytalks.net/?p=6787">Nima Majlesi (New Jersey): Ice Bath is the Best Method to Cool Hyperthermic Patients</a></li><li><a
href="http://freeemergencytalks.net/?p=6791">Richard Shih (New Jersey): Is Activated Charcoal Useful for Toxicity from Plant Ingestions?</a></li></ul><h4><strong>Day 3: HEENT Emergencies</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6796">Kevin Reed (Maryland): What Really Helps a Sore Throat</a></li><li><a
href="http://freeemergencytalks.net/?p=6799">Juliusz Jakubaszko (Poland): Rapid Sequence Intubation &#8211; A Good Option for the Emergency Physician</a></li><li><a
href="http://freeemergencytalks.net/?p=6802">Polat Durukan (Turkey): Spinal Trauma Radiology in Cervical or Head Trauma</a></li><li><a
href="http://freeemergencytalks.net/?p=6805">Kenneth Butler (Maryland): Current Devices in Airway Management</a></li><li><a
href="http://freeemergencytalks.net/?p=6808">Christopher Lee (New York): Vertigo &#8211; Differentiating Between Central and Peripheral</a></li><li><a
href="http://freeemergencytalks.net/?p=6811">Nausheen Doctor (Singapore): Benzodiazepines or Antipsychotics for the Acutely Agitated Patient</a></li></ul><h4><strong>Day 3: Ultrasound in Emergency Medicine</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6814">Rajat &#8216;Rip&#8217; Gangahar (United Kingdom): IFEM International Point of Care Emergency Ultrasound Faculty</a></li><li><a
href="http://freeemergencytalks.net/?p=6817">Paola Molino (Italy): Emergency Ultrasound in Cardiac Arrest</a></li><li><a
href="http://freeemergencytalks.net/?p=6820">Lisa D. Mills (California): Ultrasound in Hand Emergencies</a></li><li><a
href="http://freeemergencytalks.net/?p=6823">Joseph Wood (Arizona): Sonographic Assessment of Medical Emergencies (S.A.M.E.)</a></li><li><a
href="http://freeemergencytalks.net/?p=6826">Melanie Stander (South Africa): Vascular Applications of Emergency Point of Care Ultrasound</a></li><li><a
href="http://freeemergencytalks.net/?p=6829">Paolo Molino (Italy): Bedside Ultrasound in Acute Dyspnea</a></li></ul><h4><strong>Day 3: Administration</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6833">Kenneth Butler (Maryland): Emergency Medical Care at Academic Medical Centers and Community Hospitals &#8211; A Comparison</a></li><li><a
href="http://freeemergencytalks.net/?p=6836">Eric Revue (France): Overcrowding</a></li><li><a
href="http://freeemergencytalks.net/?p=6839">Mark Reiter (Pennsylvania): Safety and Quality Key Performance Indicators</a></li><li><a
href="http://freeemergencytalks.net/?p=6842">Nathalie Flacke (France): Knowledge Management</a></li><li><a
href="http://freeemergencytalks.net/?p=6845">Manuel Hernandez (Illinois): Use of Computerized Simulation Modeling for Process Redesign</a></li><li><a
href="http://freeemergencytalks.net/?p=6848">Paul Barach (Australia): Patient Handovers / Hand-offs</a></li><li><a
href="http://freeemergencytalks.net/?p=6851">Luis Garcia Castrillo Riesco (Spain): Technologies in Building a Hospital Database Network</a></li><li><a
href="http://freeemergencytalks.net/?p=6854">Gerald Kierzek (France): Medico-Legal Issues in Emergency Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6857">Michael Christ (Germany): Reducing Mortality in Community Acquired Pneumonia</a></li><li><a
href="http://freeemergencytalks.net/?p=6860">Lisa Moreno-Walton (Louisiana): Mentorship in Action &#8211; Benefits and Techniques</a></li><li><a
href="http://freeemergencytalks.net/?p=6863">Nathalie Flacke (France): The Challenges of Female Leadership in Medicine</a></li><li><a
href="http://freeemergencytalks.net/?p=6866">Juliana Poh (Singapore): Prescribing for Common Conditions in the Elderly</a></li></ul><h4><strong>Day 3: Research</strong></h4><ul><li><a
href="http://freeemergencytalks.net/?p=6870">Gary Gaddis (Kansas): Knowledge Translation &#8211; Clinical Decision Rules</a></li><li><a
href="http://freeemergencytalks.net/?p=6873">Luis Garcia Castrillo Riesco (Spain): Data Mining Opportunities for Public Health Monitoring</a></li><li><a
href="http://freeemergencytalks.net/?p=6876">David Salo (New Jersey): Basic Research Statistics &#8211; P Values and Confidence Intervals</a></li><li><a
href="http://freeemergencytalks.net/?p=6879">Ana Maria Navio Serrano (Spain): The I.S.S.S. Study (International Score of Shock Severity)</a></li><li><a
href="http://freeemergencytalks.net/?p=6882">Brenna Farmer (New York): Toxicology Research &#8211; Fruitful Areas and Pitfalls</a></li><li><a
href="http://freeemergencytalks.net/?p=6886">Juliana Poh (Singapore): Using Research in Planning Geriatric Emergency Care</a></li><li><a
href="http://freeemergencytalks.net/?p=6889">Nausheen Doctor (Singapore): Asian Resuscitation Outcomes for Out-of-Hospital Cardiac Arrests</a></li><li><a
href="http://freeemergencytalks.net/?p=6892">Roberto Cosentini (Italy): Research in Noninvasive Ventilation &#8211; Can It Be Done in our Busy EDs?</a></li><li><a
href="http://freeemergencytalks.net/?p=6895">Lisa Moreno-Walton (Louisiana): Pearls and Pitfalls in the Design of a Survey Study</a></li><li><a
href="http://freeemergencytalks.net/?p=6898">William Barsan (Michigan): NETT &#8211; The Neurological Emergencies Treatment Trials Network</a></li><li><a
href="http://freeemergencytalks.net/?p=6901">Colin A. Graham (Hong Kong): How Original Studies Could be Published in the European Journal of Emergency Medicine or Other Emergency Journals</a></li></ul><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2011/12/memc-vi/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>Emergency Medicine in the Developing World 2011 (Part 2)</title><link>http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-2/</link> <comments>http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-2/#comments</comments> <pubDate>Fri, 18 Nov 2011 14:33:36 +0000</pubDate> <dc:creator>Chris Nickson</dc:creator> <category><![CDATA[Conference]]></category> <category><![CDATA[Emergency Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[International Emergency Medicine]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Emergency Medicine for the Developing World]]></category> <category><![CDATA[EMSSA]]></category> <category><![CDATA[IEM]]></category> <category><![CDATA[international emergency medicine]]></category> <category><![CDATA[Ross Hofmeyer]]></category> <category><![CDATA[sa'ad lahri]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=46090</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-2/">Emergency Medicine in the Developing World 2011 (Part 2)</a></p><p>Key points and pearls from the the big hitting speakers at the 3rd biennial 'Emergency Medicine in the Developing World' conference currently being hosted by EMSSA in Cape Town.</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-2/">Emergency Medicine in the Developing World 2011 (Part 2)</a></p><p>You&#8217;ll remember from <a
href="http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-1/">Part 1</a> that the 3rd biennial <a
href="http://www.2011.emssa.org.za/">&#8216;<strong>Emergency Medicine in the Developing World</strong>&#8216; <strong>conference</strong></a> is being hosted in Cape Town, by the Emergency Medicine Society of South Africa (<a
href="http://emssa.org.za/">EMSSA</a>).  LITFL friend <strong>Sa&#8217;ad Lahri</strong> (from <a
href="http://lifeinthefastlane.com/2011/03/gf-jooste-hospital-experience/">GF Jooste Hospital</a>) is on the conference committee and feeding us a series of key points and pearls typed on the fly by <strong><a
href="http://wildmedic.co.za/">Ross Hofmeyer</a></strong>. These notes are from Day 2 of the conference.  The audio of these talks are to be made available on <a
href="http://freeemergencytalks.net/">Free Emergency Medicine Talks</a> in the near future.</p><p>Let&#8217;s rip into it&#8230;</p><p><strong><a
style="display:none;" id="ddetlink439946450" href="javascript:expand(document.getElementById('ddet439946450'))">Blood Transfusion Alternatives – Eric Hodgson (Breakfast Symposium)</a><div
class="ddet_div" id="ddet439946450"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet439946450'));expand(document.getElementById('ddetlink439946450'))</script></strong></p><ul><li>Increase in demand for blood transfusion products but decreasing supply</li><li>African HIV epidemic straining supplies</li><li>Acute resus – Hb &gt; 10g/dL probably required</li><li>ICU/longer term – Hb &gt;7 g/dL should be sufficient unless background illness</li><li>Tissue oxygenation is what counts, not Hb (DO2 is the most important)</li><li>DO2 requires absolute minimum Hb 3 g/dL</li><li>Extraction reserve from Hb 25-75% (1-3 molecules ‘extra’ under normal conditions)</li><li>Increase a-v O2 gradient implies patient is nearing limit of reserve</li><li> ScvO2 use paired with ABG can thus be used as a guide (ala Rivers EGDT)</li><li>Lactate increase follows after decrease in ScvO2</li><li>ScvO2 &gt;70% and/or lactate &gt;8 may be a good triage criterion</li><li>Patient’s blood is best – keep it in!</li><li>Maintain normothermia – one litre of room-air fluid can drop core temperature by 0.5-1 degree C</li><li>Blood conservation in trauma – permissive hypotension where it is not contra-indicated. In SA with long delays (&gt;90 minutes) need some more resus – aim for SBP&gt;100/MAP&gt;60. Vasopressin being researched.</li><li>Hemopure:</li></ul><blockquote><ul><li>3 year shelf life</li><li>Bovine haemoglobin</li><li>Functions as a colloid – no clotting factors</li><li>Hypertension with rapid administration (due to NO binding)</li><li>Bridge to transfusion/neosynthesis of blood (Iron available in the Hemopure; increased EPO due to decreased red cell mass)</li></ul></blockquote><ul><li>HBBS given a bad name by a very flawed meta-analysis</li><li>Potential uses of blood substitutes are legion</li><li>Blood conservation – intraoperative cell salvage (Takagi Arch Surg 2007). Can be used with a fresh bowel perforation</li><li>Anticoagulation:</li></ul><blockquote><ul><li>Platelets effective in 4hrs after aspirin and 12 hrs after clopidogrel</li><li>Warfarin can be reversed in minutes with PCC(Haemosolvex), hours with FFP and days with Vitamin K</li><li>Best assessed with TEG if available.</li></ul></blockquote><ul><li>Aim for</li></ul><blockquote><ul><li>Platelets &gt;50 (if bleeding)</li><li>PTT &lt; 2x control</li><li>Fibrinogen &lt;1 -&gt; cryoprecipitate</li><li>Fibrinogen 1-2 -&gt; 1-2u plasma</li><li>Fibrinogen &gt;2 -&gt; possible error; consider tranexamic acid</li></ul></blockquote><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1251216668" href="javascript:expand(document.getElementById('ddet1251216668'))">Haemopure – An Alternative to Acute Anaemia Management for the Developing World – Colin Mackenzie (Breakfast Symposium)</a><div
class="ddet_div" id="ddet1251216668"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1251216668'));expand(document.getElementById('ddetlink1251216668'))</script></strong></p><p><strong>Conflicts of interest declared.</strong></p><ul><li>UMD Shock Trauma – about 70% of trauma patients need no more than 2-3 units of packed red blood cells</li><li>HBOC vs RBC – Bovine Hb vs human, higher O2 carrying capacity, much less viscosity, much shorter half-life; long shelf life. (Similar oncotic pressure etc).</li><li>Hemopure:</li></ul><blockquote><ul><li>No cross-match/typing needed</li><li>Ready-to-use</li><li>No know disease transmission</li><li>Can be stored at 4-30 degrees for 3 years</li><li>Carries O2 and treats hypovolaemia</li><li>No known immune effects</li><li>Rheological advantage</li></ul></blockquote><ul><li>Fewer resources and less infrastructure required to maintain a supply of HBOC rather than blood.</li><li>Transfusion errors are not an issue due to lack of cross-match requirement.</li><li>Testing blood for transmitted diseases now accounts for 50% of the cost of a unit.</li><li>Is Hemopure safe and efficacious?</li></ul><blockquote><ul><li>HEM-115 study (n=688) – no mortality difference</li><li>Moderate needs (&lt;3u) side effects and mortality identical</li><li>No MI’s in patients receiving &lt;10u in Hemopure arm and one in RBC arm</li></ul></blockquote><ul><li>Several case studies presented</li><li>Best use = when blood is not available or accessible.</li><li>JAMA meta-analysis (May 2008) – 5 different HBOC’s analysed as one group, 2 of which had already been withdrawn more than a decade before the meta-analysis was done. Removing 1 of these would change the result to positive!</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink830333777" href="javascript:expand(document.getElementById('ddet830333777'))">Emergency Management of Acute Intracerebral Haemorrhage – Joshua Goldstein</a><div
class="ddet_div" id="ddet830333777"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet830333777'));expand(document.getElementById('ddetlink830333777'))</script></strong></p><ul><li>Talk focus: primary intraparencymal/intracerebral haemorrhage</li><li>Constitutes 10-15% of strokes with mortality between 35 and 52%</li><li>Locations: brainstem, cerebellum, thalamus, basal ganglia, lobar.</li><li>Initial diagnosis: abrupt headache, vomiting, seizure, altered mental state, any focal or generalised neurological symptoms, and otherwise the same for acute stroke.</li><li>EMS evaluation: ABCs, cardiac monitoring, IV access, O2 if hypoxic, NPO, alert and transfer</li><li>Initial care: as per ‘suspected stroke’. Balance risk of loss of airway against loss of neuro exam. CT head ASAP whenever available.</li><li>Major predictors of outcome: Initial GCS and ICH volume</li><li>Factors associated with poor outcome that we can treat:</li></ul><blockquote><ul><li>Hematoma expansion</li><li>Hyperglycemia</li><li>Hematoma evacuation</li><li>Seizures</li></ul></blockquote><ul><li>Hematoma expansion – 38% of patients presenting within 3 hours of onset have significant haematoma growth .</li></ul><blockquote><ul><li>Blood pressure control is controversial – minimal literature available (most of it intra-operative from neurosurgery). ‘Resetting’ of CBF autoregulation to a higher-than-normal level is a concern. INTERACT study (SBP&lt;180 vs SBP&lt;140): 36% decreased risk of haematoma expansion, but no effect on outcome. INTERACT2 (specifically powered to measure outcome effect) is currently underway. AHA guidelines exist (all class C) advising a moderate decrease in BP</li><li>Anticoagulation reversal – FFP use to reverse warfarin (contains factors II, VII, IX and X required) can require 10u (2000ml) to reverse INR. This can be a problem in patients with background of cardiac disease (for which they get the warfarin…). Time to reversal varies in studies: 7-32 hours due to practical considerations. PCC (prothrombin complex concentrate) has rapid action (about 20 minutes) with minimum volume required, but they are expensive and carry a risk of thrombotic complications and DIC. IV Vitamin K has an effect as early as 4 hours, and can reverse the INR as early as 8 hours. Risks include anaphylaxis (rare). Factor VIIa also reverses the INR within minutes, but once again there is a risk of increased thrombotic complication.</li></ul></blockquote><ul><li>Hyperglycaemia</li></ul><blockquote><ul><li>Associated with poor outcome, even in the absence of diabetes. Hyperglycaemia is neurotoxic.</li><li>GIST trial – n=933 (12% ICH), intensive insulin vs. sliding scale: No difference in outcome</li><li>QASC trial – n=1696 (5% ICH), glucose control vs. none (intervention group also had swallow screen and paracetamol for fever): Poor outcome 42 vs 58%</li></ul></blockquote><ul><li>Large haematoma: surgical evacuation</li></ul><blockquote><ul><li>STICH trial – n=477+505: OR 0.89 (CI 0.66-1.19) therefore no benefit to urgent evacuation</li><li>EVD placement for intraventricular blood – never been studied and probably never will be, as most people presume drainage of obstructive hydrocephalus is obvious.</li></ul></blockquote><ul><li>Clinical seizures should be treated with anti-epileptics; routine prophylaxis is not indicated.</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink925408757" href="javascript:expand(document.getElementById('ddet925408757'))">Intubation: Preventing the Clean Kill – Sa’ad Lahri</a><div
class="ddet_div" id="ddet925408757"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet925408757'));expand(document.getElementById('ddetlink925408757'))</script></strong></p><ul><li>Most discuss the anatomically difficult airway – what about the physiologically difficult airway?</li><li>Pre-oxygenation vs. denitrogenation</li><li>Patients who are not breathing adequately cannot pre-oxygenate adequately!</li><li>Most patients needing intubation have some degree of physiological shunt</li><li>Overcoming shunt relies on increasing the mean airway pressure</li><li>BVM pre-oxygenation relies on assisted ventilation and a good mask seal… and you NEED A PEEP VALVE</li><li>NIV (CPAP) can be used for pre-oxygenation in the ED</li><li>Concept – using nasal oxygen while performing intubation to allow continued insufflation</li><li>Patient position for intubation (ear to sternal notch) assists ‘apnoeic oxygenation’</li><li>“Delayed Sequence Intuabtion” for the delirious patient using ketamine (or dexmedetomidine or fentanyl &amp; midaz titrated).</li><li>Bicarb to buy time in severe acidosis?</li><li>‘Push dose’ pressors for pre-emptive control of drop in BP on induction – phenylephrine</li><li>Induction agents – ketamine or etomidate, but beware patients with maximum sympathetic stimulation – decrease dose.</li><li>Beware hypoventilation post intubation – measure ABG and watch pCO2</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink849152318" href="javascript:expand(document.getElementById('ddet849152318'))">Dysrhythmia Management: The Fast, the Furious and the Feeble – Walther Kloek</a><div
class="ddet_div" id="ddet849152318"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet849152318'));expand(document.getElementById('ddetlink849152318'))</script></strong></p><ul><li>ABCDE approach as a basis</li><li>E = ECG – get a rhythm strip as a minimum, 12 lead ECG by preference</li><li>The Feeble – Bradycardia:</li><li>Signs of instability: hypotension, altered mental state, signs of shock, ischaemic pain/discomfort, acute heart failure.</li></ul><blockquote><ul><li>Before giving atropine, exclude: hypoxia, hypothermia and head injury. Be cautious in head injury, hyperkalaemia and heart transplant.</li><li>If atropine is unsuccessful, consider adrenaline, dopamine, glucagon (beta- or Ca-channel blockage OD) or pacing</li></ul></blockquote><ul><li> The Fast – Narrow Complex Tachycardia</li></ul><blockquote><ul><li>HR&gt;150 with QRS&lt;0.12sec</li><li>If unstable: Cardiovert!</li><li>If stable: vagal manoeuvres – Valsalva, facial application of ice water, carotid sinus massage</li><li>or: drugs &#8212; Amiodarone, Beta-blockers, Ca-channel blockers, Digoxin</li></ul></blockquote><ul><li>The Furious – Wide Complex Tachycardia</li></ul><blockquote><ul><li>Usually unstable, but if stable, consider adenosine but amiodarone is the drug of choice</li><li>Cardiovert if unstable</li></ul></blockquote><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1715608297" href="javascript:expand(document.getElementById('ddet1715608297'))">Current Management of Heart Failure – Doug Ander</a><div
class="ddet_div" id="ddet1715608297"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1715608297'));expand(document.getElementById('ddetlink1715608297'))</script></strong></p><ul><li>Diagnosis is difficult based on common variables – limited sensitivity of physical examination, ECG and CXR (normal in 20%)</li><li>BNP &gt;100pg/ml is more accurate than clinical criteria for diagnosis, but cannot be used alone. Greatest value is for the ‘intermediate’ patients. May be lower than expected in flash pulmonary oedema. Mild elevation can be found in cor pulmonale, PE and COPD. Inverse relationship with BMI and higher with renal failure.</li><li>Ultrasound for “lung comets” has proven to have good sensitivity in initial studies</li><li>ASCEND-HF clinical decision pathway useful in hypertensives</li><li>Morphine has gone out of favour – not good evidence. Perhaps good if intubation is inevitable</li><li>Nitrates very effective in controlling BP and reducing afterload</li><li>ACE-I may work – small studies showed decreased intubation rates</li><li>Furosemide helpful in the acute setting but nitrates better</li><li>NIV excellent</li><li>Hypotensive patients – fluid bolus if intravascularly depleted, then inotropes</li><li>Don’t forget to consider palliative care in the correct cases.</li><li>Ultrafiltration can be useful if it is available (although it is expensive and time intensive)</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1537380385" href="javascript:expand(document.getElementById('ddet1537380385'))">Keynote: A Skeptic’s Guide to Reading the Medical Literature - Joe Lex</a><div
class="ddet_div" id="ddet1537380385"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1537380385'));expand(document.getElementById('ddetlink1537380385'))</script></strong></p><ul><li>See <a
href="http://freeemergencytalks.net/">Free Emergency Medicine Talks</a> for talks – everything from this conference will also be there soon!</li><li>Be a skeptic, not a cynic</li><li>There are now more than 10 000 medical journals (a logarithmic increase!)</li><li>Remember that journals need to make money to survive. They have no fiduciary relationship with patients!</li><li>Peer review is the best we have – but it is a “flawed process at the heart of science” (in the words of the editor of the BMJ). It is prone to bias and abuse, and hopeless at spotting fraud and error. “Like poetry, love or justice”. “If peer review was a drug, it would never get onto the market.”</li><li>Publishing negative results, despite the quality of the study, is unpopular with readers and journal editors alike. However, consistent bias in reporting positive findings only skews the statistics when meta-analysis is done.</li><li>Peer review misses things – demonstrated in studies (see Baxt WB et al 1998)</li><li>Looking at articles, watch out for independent predictors, strong associations, citation bias, amplification, invention, work-up bias, spectrum bias, referral bias and so on</li><li>Least favourite statistic – Negative Predictive Value. If disease prevalence is low, the NPV will OF COURSE be low.</li><li>Citation bias – citing only articles that support our hypothesis</li><li>Beware multiple hypotheses!</li><li>Absolute vs relative risk reductions (eg. statins – JUPITER trial). Absolute risk from 0.7% to 0.4% is a 43% relative risk reduction…</li><li>Beware surrogate and composite endpoints!</li><li>Full slideset available from Prof Lex via email (as are the references)</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1919417800" href="javascript:expand(document.getElementById('ddet1919417800'))">Keynote: An integrated, ethically-driven environmental model of clinical decision making - Lisa Wolf</a><div
class="ddet_div" id="ddet1919417800"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1919417800'));expand(document.getElementById('ddetlink1919417800'))</script></strong></p><ul><li>119 million patients seen in ED’s in USA in 2009</li><li>Who drives patient care in emergency settings? Doctors, nurses, hospitalists, patients?</li><li>Ethnographic study of acuity assignation (2010)</li></ul><blockquote><ul><li>Sample of emergency nurses, ethnographic approach, 12 participants, 150 initial patient encounters over 3 months</li><li>Patients reported acuity to be a function of patient presentation, complaint, duration of symptoms and body habitus. Acuity was also influenced by environmental and contextual challenges: language barriers, patient volume, unit leadership, communication with patients and providers, and length of time in waiting room prior to triage.</li><li>“Who’s in the back?” phenomenon – some nurses made decisions about acuity, further assessment and initial diagnostic tests based solely on the physician was.</li><li>Physiologic data was not rigorously collected nor considered as a primary determinant of acuity.</li><li>Moral reasoning and drive surfaced as an important factor.</li></ul></blockquote><ul><li>Investigation of triage competency (2011)</li></ul><blockquote><ul><li>Lack of understanding around critical cues – the signs, symptoms and history that send the provider down one path and away from another.</li><li>Intuitive vs hypothetico-deductive thinking – the former is efficient but inaccurate, where the latter is accurate but time-consuming</li></ul></blockquote><ul><li>Core, intermediate and influential elements need to be considered in an integrative model for clinical decision making</li><li>Unit leadership is the best surrogate for (the almost impossible to teach concept of) moral reasoning</li><li>Proclivity for high moral reasoning is the factor that closes the loop in critical thinking; it inspires us to ask the questions “Am I right?” and “Is there a way I can be wrong?”</li><li>Important elements to consider:</li></ul><blockquote><ul><li>Knowledge base</li><li>Moral reasoning</li><li>Drive to act</li><li>Environmental structure:</li></ul></blockquote><ul><li>Standards</li><li>Communication</li><li>Teamwork</li><li>Autonomy of practice</li><li>“The end result of critical thinking is not thought: it is action”</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1634980984" href="javascript:expand(document.getElementById('ddet1634980984'))">Difficult Airway Management: Case Studies – Chuck Pozner</a><div
class="ddet_div" id="ddet1634980984"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1634980984'));expand(document.getElementById('ddetlink1634980984'))</script></strong></p><ul><li>Preparation and practice are key to being ready to manage difficult airways</li><li>Four important questions:</li></ul><blockquote><ul><li>Is the airway difficult &#8211; Anatomic concerns?</li><li>Is the patient compromised &#8211; Physiologic concerns?</li><li>What is your primary approach?</li><li>What is your rescue approach?</li></ul></blockquote><ul><li>Difficult airway situations to anticipate:</li></ul><blockquote><ul><li>Difficult DL – LEMON – Look externally, Evaluate 3-3-2, Mallampati, Obstruction &amp; Obesity, Neck movements</li><li>Difficult facemask – MOANS – Mask seal (anatomical abnormality, wounds, beards, etc), Obstruction &amp; Obesity, Age (extremes), No teeth, Stiff (difficult ventilation)</li><li>Difficult EGD (Extraglottic device) – RODS – Restricted mouth opening, Obstruction &amp; Obesity, Distortion, Stiff lungs or c-Spine</li><li>Difficult cric – SHORT – Surgery or disrupted airway, Haematoma (or other mass), Obstruction &amp; Obesity, Radiation therapy, Tumour</li></ul></blockquote><ul><li>Difficult airway principles:</li></ul><blockquote><ul><li>Patients need oxygen… not necessarily and ETT</li><li>Patients with multiple difficult airway attributes may be unsafe for paralytics</li><li>“One-shot” airways may need paralysis if you’re forced to act</li><li>Always have a backup plan</li></ul></blockquote><ul><li>Primary Airway Management Plan?</li></ul><blockquote><ul><li>RSI?</li><li>Sedated, awake intubation?</li><li>Primary surgical airway?</li><li>One always needs an airway rescue plan: Double set-up, extraglottic, or something else?</li></ul><p>Airway rescue plan?</p><ul><li>RSI?</li><li>Rescue surgical airway?</li><li>Alternative airway devices</li></ul></blockquote><ul><li>Alternative airway devices</li></ul><blockquote><ul><li>Blind insertion device?</li><li>Optical stylet?</li><li>Video laryngoscopy?</li><li>Flexible fiberoptic?</li></ul></blockquote><ul><li>Case 1: Angio-oedema (68yr female, just started on ACE-I)</li></ul><blockquote><ul><li>Good plan – Awake intubation, flexible fiberoptic if possible, surgical airway as ultimate backup.</li><li>Dry and anaesthetise the airway – atomised and nebulised lignocaine. Nasal approach with flexible fiberscope. Judicious sedation or none at all. Surgical airway if precipitous failure.</li></ul></blockquote><ul><li>Case 2: Aspirated foreign body (62yr male, “choking”, collapses in ED)</li></ul><blockquote><ul><li>Good plan – “crash airway” -&gt; immediate DL, remove foreign body if seen, intubate and ventilate if possible.</li><li>If obstruction is infraglottic, use ETT to push it all the way down into a bronchus, retract ETT and try again to ventilate.</li></ul></blockquote><ul><li>Case 3: Severe Asthmatic (25yr female, tachycardic &amp; tachypnoeic, beginning to desaturate)</li></ul><blockquote><ul><li>Rapid RSI; EGD as backup; cric if complete failure</li><li>Lignocaine nebusised if time to reduce reactive airways</li><li>Ketamine good</li></ul></blockquote><ul><li>Summary: All in the evaluation</li><li>Know your mnemonics</li><li>Always have a plan B</li><li>Remember some nuacnces of specific cases</li><li>Practice practice practice</li></ul><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1606915566" href="javascript:expand(document.getElementById('ddet1606915566'))">Care in Austere Circumstances - Theo Ligthelm</a><div
class="ddet_div" id="ddet1606915566"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1606915566'));expand(document.getElementById('ddetlink1606915566'))</script></strong></p><ul><li>1:2:4 principle</li></ul><blockquote><ul><li>most casualties on the battlefield still bleed to death</li><li>Emergency care/ ALS within 1 hour</li><li>Surgical resuscitation within 2 hours</li><li>Definitive care within 4 hours</li></ul></blockquote><ul><li>Level 1 resuscitation post as close to the battlefield as possible</li><li>Forward surgical capabilities near the battlefield</li><li>Rapid evacuation to definitive care at field hospital care on land/rail/sea and even in the air.</li><li>Caring for patients under the special circumstances such as chem/bio/nuke threats</li><li>Military fatality rates – major death in &lt;5min and 11-30min time brackets.  &lt;5 usually fatally wounded; focus on the 11-30min bracket</li><li>78% of injuries now are blast injuries rather than gunshots in modern warfare</li><li> Potentially survivable deaths – 85% due to haemorrhage! Of this, 31% is compressible haemorrhage…</li><li>Algorithm starts with a C – Catastrophic Haemorrhage Control</li><li>Tourniquets save lives and red blood cells</li><li>Combat ready clamp for femoral artery and abdominal aorta tourniquet (inflatable wedge)</li><li>Internal Compression tourniquet especially useful in “junctional trauma” (shoulder and groin)</li><li>Extensive use of topical hemostatic agents (haemostatic bandages and combat guaze)</li><li>Tranexamic acid extensively supported in military literature</li><li>10-15% of preventable deaths due to airway obstruction</li><li>NPA useful and well tolerated in semi-conscious patients and is extensively used</li><li>Endotracheal intubation in the battlefield is not the answer (1 survival out of 492 cases)</li><li>Surgical airway is the first and last resort</li><li>Tension pneumothorax is a common cause of preventable death – bilateral needle decompression performed before calling death</li><li>Hemopure for blood substitute</li><li>Hypotensive resuscitation used</li><li>Intra-osseous lines in sternum and tibia very useful</li><li>Focus on resuscitation with blood products early</li><li>“In combat settings, casualties without head injury who are of normal mental status with a palpable radial pulse should not receive fluid resuscitation”</li><li>1:1:1 resus (or even higher ratios – 2:3)</li><li>Body warming bags and fluid warmers in vehicles</li><li>Damage control surgery very well adopted</li><li>Low threshold for early damage control</li><li>Ethical challenges:</li></ul><blockquote><ul><li>Law of war (especially peace missions)</li><li>Civilian casualties</li><li>Own vs. enemy forces</li><li>Iraq – 93% of casualties are non-combatants, 34% under 14 years of age</li><li>Patients full of explosives… children with explosive belts… incubators with babies booby-trapped with explosives…</li><li>Prisoners of war</li></ul></blockquote><ul><li>Paradigm challenges</li></ul><blockquote><ul><li>Triage is fighting force orientated – get the healthiest fighting again fast</li><li>Quality compassionate care is possible under austere conditions</li><li>Unique approaches are required.</li></ul></blockquote><p><strong></div></strong></p><p><strong><a
style="display:none;" id="ddetlink1178315837" href="javascript:expand(document.getElementById('ddet1178315837'))">HPCSA EMS Protocols – Martin Botha</a><div
class="ddet_div" id="ddet1178315837"><script language="JavaScript" type="text/javascript">expand(document.getElementById('ddet1178315837'));expand(document.getElementById('ddetlink1178315837'))</script></strong></p><ul><li>Consensus – mutually acceptable agreement that integrates interests of all parties, but does not require unanimous consent. All parties should be committed to its implementation.</li><li>Consensus on science is the most important.</li><li>Consensus on treatment recommendations is desirable, but only if there is good agreement</li><li>We need professionals with good research skills to develop evidence-based guidelines for SA EMS</li><li>(ILCOR process for analysing evidence and presenting it to consensus meeting demonstrated)</li><li>GRADE approach is becoming the standard assessment tool</li><li>HPCSA has begun the processes to review and develop protocols along these lines.</li><li>Questions and debates:</li></ul><blockquote><ul><li>What is the role of protocols for independent practitioners in SA?</li><li>What is the role of protocols for EMS Professionals?</li><li>Varying levels of experience, training, scope of practice, clinical governance, models and self-regulation.</li><li>How to integrate changes quickly into guidelines to reflect current best evidence?</li></ul></blockquote><p><strong></div></strong></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2011/11/emergency-medicine-in-the-developing-world-2011-part-2/feed/</wfw:commentRss> <slash:comments>3</slash:comments> </item> <item><title>EBM Community Acquired Pneumonia</title><link>http://lifeinthefastlane.com/2010/11/ebm-cap/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-cap/#comments</comments> <pubDate>Mon, 22 Nov 2010 02:00:00 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[Respiratory]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[cap]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[pneumonia]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27113</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-cap/">EBM Community Acquired Pneumonia</a></p><p>Community Acquired Pneumonia EBM Review</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-cap/">EBM Community Acquired Pneumonia</a></p><p
align="right"><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Community Acquired Pneumonia in Adults</span></h4><p><strong> </strong></p><ul><li>Risk factors for CAP include:<ul><li>Age over 50 years, asthma, smoking, pre-existing COPD, DM, CRF, CCF, alcoholism, liver disease, neoplasia, stroke, seizures, aspiration, immunosuppression, institutionalisation, indigenous.</li></ul></li></ul><blockquote><p>Johnson P, Irving L et al. Community-acquired pneumonia. <em>MJA </em>2002; 	176:341-347 [<a
href="http://www.mja.com.au/public/issues/176_07_010402/joh10289_fm.html" target="_blank">Reference</a>]</p></blockquote><ul><li>Note that a normal CXR in a bed-ridden patient with suspected pneumonia does <em>not</em> rule it out (NPV 65%) and so CT may be indicated to confirm.</li></ul><blockquote><p>Esayag Y, Nikitin I, Bar-Ziv J et al. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. <em>Am J Med</em> 2010;123:88.e1-88.e6. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20102999" target="_blank">Reference</a>]</p></blockquote><ul><li>Most common organism is <em>Strep pneumoniae</em> + causes most severe illness 	and deaths, especially in the elderly. Also <em>Mycoplasma pneumoniae</em>, <em>Chlamydophila pneumoniae</em>, <em>Legionella</em> and <em>H.influenzae</em> (usually in COPD)<ul><li>Note rapid urinary antigen tests available for <em>Strep pneumonia </em>and 				  <em>Legionella</em>, recommended in moderate to severe CAP.</li></ul></li><li>‘Red flags’ for severe illness mandating admission include RR &gt; 30/min, SBP 	&lt; 90 mmHg, SaO<sub>2</sub> &lt; 92%, acute confusion, pH &lt; 7.35, PaO<sub>2</sub> &lt; 60 mmHg and 	multilobar involvement on CXR.</li><li>Australian-derived severity scoring system for use when CAP is confirmed on CXR, dichotomoised for patients more than 50 years or ≤ 50 yr, is known as SMART-COP, and is scored out of 11.<ul><li>A score of 3-4 gives a 1:8 risk of needing intensive respiratory or vasopressor support (IRVS).</li><li>SMART-COP score ≥ 5 gives a 1:3 risk needing IRVS = severe CAP.</li><li>Better predicts need for IRVS / ICU than the Pneumonia Severity Index (PSI) or CURB-65 score, which are more heavily dependent of age and co-morbid illness in predicting 30-day mortality.</li></ul></li></ul><blockquote><p>Charles P, Wolfe R, Whitby M et al. SMART-COP: A tool for predicting 	the need for intensive respiratory or vasopressor support in community acquired pneumonia. <em>Clin Infect Dis</em> 2008;47:375-84. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18558884" target="_blank">Reference</a>]</p></blockquote><ul><li>Alternative scoring system is the 5-point <strong>CURB-65</strong> score, with one point for 	each of <strong>C</strong>onfusion, <strong>U</strong>rea &gt; 7 mmol/l, <strong>R</strong>esp rate  ≥ 30/min, <strong>B</strong>lood pressure low 	(SBP &lt; 90 mmHg or DBP ≤ 60 mmHg), age ≥ <strong>65</strong> yr.<ul><li>Score 4 = 41.5%, and score 5 = 57% mortality or need for ICU.</li><li>Score 0 or 1 = 0.7% and 3.2% mortality respectively.</li><li>Thus score 0 or 1 patients could be treated at home, score 2 patients need hospital assessment and ≥ 3 are considered severe. Score ≥ 4 need referral to ICU.</li></ul></li></ul><blockquote><p>Lim WS et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. <em>Thorax</em> 2003;58:377-82. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/12728155" target="_blank">Reference</a>]</p></blockquote><ul><li>Give empiric antibiotic treatment <em>after</em> 2 sets of blood cultures from separate venepuncture sites if severe (5-10% yield), and sputum if rapidly available (do not delay treatment to collect sputum, as yield ≤ 40% only).</li><li><strong>Mild CAP:</strong><ul><li>Give amoxicillin 1 g PO 8-hourly for 5-7 days. Or if <em>Mycoplasma pneumoniae</em>, <em>Chlamydophila pneumoniae</em> or <em>Legionella</em> is suspected, use doxycycline 200 mg PO for first dose then 100 mg PO daily for 5 days instead, or clarithromycin 250 mg PO bd f or 5-7 days.</li><li>Patients who fail to improve by 48 hours of amoxicillin PO should have doxycycline or clarithromycin added to their regime.</li><li>If history of immediate hypersensitivity to penicillin, give doxycycline or moxifloxacin 400 mg PO daily, depending on local practice.</li></ul></li><li><strong>Moderate severity CAP:</strong><ul><li>Patients requiring hospital admission, give benzyl penicillin 1.2 g IV 6-hourly until significant improvement then change to amoxicillin 1 g PO 	8-hourly for 7 days, <em>plus</em> either doxycycline 100 mg PO 12-hourly for 7 	days or clarithromycin 500 mg PO 12-hourly for 7 days.</li><li>Add gentamicin 5 mg/kg IV daily (assuming normal renal function) if Gram-negative bacilli are identified in blood or sputum. Alternatively, change the benzyl penicillin to ceftriaxone 1 g daily IV.</li><li>If patient has immediate hypersensitivity to penicillin, substitute ceftriaxone 1 g daily IV for the penicillin, or use moxifloxacin 400 mg PO daily monotherapy as a single drug.</li><li>Tropical areas, if the patient has risk factors for meliodosis (diabetes / alcohol / CRF / lung disease), give ceftriaxone 2 g daily IV plus gentamicin 5 mg/kg IV as a single dose.</li><li>For both moderate and severe CAP admitted to hospital, consider use 	of oseltamivir 75 mg BD PO, particularly in &#8216;flu season.</li></ul></li><li><strong>Severe CAP </strong>(SMART-COP score ≥  5)<strong>:</strong><ul><li>Refer to HDU / ICU.</li><li>Give ceftriaxone 1 g IV daily; or benzyl penicillin 1.2 g IV 4-hourly with gentamicin 5 mg/kg IV daily, <em>plus</em> with either azithromycin 500 	mg 	IV daily.</li><li>If significant renal impairment or penicillin allergy, use moxifloxacin 400 mg IV daily with azithromycin.</li></ul></li><li><strong>Severe tropical pneumonia:</strong><ul><li>Where <em>Burkholderia</em> <em>pseudomallei</em> (melioidosis) or <em>Acinetobacter</em> <em>baumannii</em> are prevalent, give meropenem 1 g IV 8-hourly plus azithromycin 500 mg IV daily.</li></ul></li></ul><blockquote><p>Therapeutic Guidelines Ltd. <em>Therapeutic Guidelines. Antibiotic;</em> Version 14, 2010:221-258. [<a
href="http://lifeinthefastlane.com/2010/07/antibiotic-guidelines-2010/" target="_blank">Reference</a>]</p></blockquote><ul><li>In HIV patients, <em>pneumocystis jiroveci </em>(<em>carinii</em>) pneumonia is the commonest AIDS-defining illness and cause of death. Also TB has 100-fold increased relative risk, and can not be excluded on CXR findings alone.</li></ul><blockquote><p>Lim W, Baudouin S, George R et al. <a
href="http://www.brit-thoracic.org.uk/" target="_blank">British Thoracic Society guidelines</a> for the management of community acquired pneumonia in adults. Update 2009. Thorax 2009;64 (suppl II):iii1-iii55. [<a
href="http://www.thepcrj.org/journ/view_article.php?article_id=687" target="_blank">Reference</a>]</p><p>Mandell L, Wunderink R, Anzueto A et al. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. <em>Clin Infect Dis</em> 2007;44:Suppl 2: S27-72.  [Reference] [<a
href="http://www.thoracic.org/statements/" target="_self">Website</a>]</p><p>Eddy O. Community-acquired pneumonia: from common pathogens to emerging resistance. <em><a
href="http://www.ebmedicine.net/" target="_blank">Emergency Medicine Practice</a></em> 2005;7 (12):1-24. [<a
href="http://www.ebmedicine.net/topics.php?paction=showTopic&amp;topic_id=118" target="_blank">Website Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-cap/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>EBM Spontaneous Pneumothorax</title><link>http://lifeinthefastlane.com/2010/11/ebm-spontaneous-pneumothorax/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-spontaneous-pneumothorax/#comments</comments> <pubDate>Sun, 21 Nov 2010 02:00:42 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Emergency Medicine]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[Respiratory]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[pneumothorax]]></category> <category><![CDATA[Pthx]]></category> <category><![CDATA[spontaneous pneumothorax]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27109</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-spontaneous-pneumothorax/">EBM Spontaneous Pneumothorax</a></p><p>Spontaneous Pneumothorax in the Emergency Department an EBM Review</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-spontaneous-pneumothorax/">EBM Spontaneous Pneumothorax</a></p><p><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Clinical Appraisal</span></h4><p>Determine the following three criteria concerning the diagnosis of a spontaneous pneumothorax. Use an inspiratory CXR (PA, or lateral, if PA is normal and suspicion high). Expiratory CXRs are not recommended:</p><ul><li><strong>Chronic lung disease?</strong> (CLD): cystic, fibrotic, bullous or emphysematous lung disease. Patient will be admitted overnight <em>irrespective</em> of treatment.</li><li><strong>Degree of breathlessness?</strong> (dyspnoea): ‘Significant means any deterioration in usual exercise tolerance.</li><li><strong>Degree of collapse?</strong> (small or large):<ul><li>Small: visible rim &lt; 2 cm at level of hilum.</li><li>Large: visible rim ≥ 2 cm (equates to approximately 50% collapse).</li></ul></li></ul><h4><span
style="font-weight: normal;">Management</span></h4><p>This is dictated by absence of CLD (primary pneumothorax) or presence of CLD (secondary pneumothorax)<strong>;</strong> extent of pneumothorax on CXR (large or small)<strong>;</strong> and degree of patient’s breathlessness (dyspnoea) ie. significant or not:</p><ul><li>Non-interventional management:<ul><li>Patients <em>without</em> CLD, with no significant dyspnoea and with a small pneumothorax do NOT mandate any treatment at all.</li><li>Aspiration may however be preferred by some to hasten resolution.</li></ul></li><li>Simple aspiration under LA with 14-16 G cannula, until resistance is felt, patient coughs excessively or over 2.5 litres withdrawn:<ul><li>Perform this for a small pneumothorax with significant dyspnoea, in the absence of CLD, or for the majority of large pneumothoraces.</li><li>May be attempted in CLD for a small pneumothorax if under age 50 and minimally dyspnoeic. However, must then admit for 24 hours observation and high-flow oxygen.</li><li>Repeat CXR after aspiration and 6 hours later. If aspiration successful with resolution or only small residual air rim, no evidence continuing air leak and not dyspnoeic, discharge and arrange follow up.</li><li>Aspiration <em>may</em> be repeated if patient is still breathless and less than 2.5 L was aspirated and catheter was blocked or kinked, but ICC insertion is more likely to be needed for this ‘aspiration failure’.</li><li>Aspiration overall is safe and effective for the management of a primary  spontaneous pneumothorax, with fewer hospital admissions and, if  admitted, a shorter length of stay + appears less painful / less need for  analgesia.</li><li>However, small bore chest tube insertion (&lt; 14 F) is now possible and popular using Seldinger technique &#8211; see ICC below.</li></ul></li></ul><blockquote><p>Zehtabchi S, Rios C. Management of emergency department patients with primary spontaneous pneumothorax: needle aspiration or tube thoracostomy? <em>Ann Emerg Med</em> 2008;51:91-100. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18166436" target="_blank">Reference</a>]</p></blockquote><ul><li>Intercostal catheter (ICC) 10 – 14F, using Seldinger technique; or blunt dissection having withdrawn / discarded trocar <em>first</em>.  Note if need to replace a smaller ICC, can use a larger 20 -24 F. Small-bore ICC is indicated for:<ul><li>Following failed aspiration if patient remains breathless, or if pneumothorax relapses.</li><li>CLD patients with small pneumothorax with dyspnoea or if over 50 yrs, and all large pneumothoraces with CLD.</li><li>Bilateral pneumothorax.</li></ul></li><li>Remove ICC if stopped bubbling and CXR re-expanded.<ul><li>If continues to bubble or pneumothorax fails to re-expand by 48 hrs, consider high-volume low pressure suction system (or look for a kinked tube), and consult respiratory physician.</li><li><em>Never</em> clamp a bubbling chest tube.</li></ul></li><li>Indications for surgical advice include second ipsilateral pneumothorax, first contralateral pneumothorax, bilateral synchronous, persistent air leak / failure to expand, spontaneous haemothorax, pregnancy, at-risk profession (pilot / 	diver).</li><li>Follow up when discharged:<ul><li>All patients should be reviewed within 7-10 days by a respiratory physician. Risk of recurrence of spontaneous pneumothorax is up to 54% at 4 years, particularly in smokers, taller patients and age &gt; 60 yr.</li><li>Instruct patient to immediately re-attend Emergency if develops significant dyspnoea or increasing pain.</li><li>Advise those allowed home to <em>stop smoking</em>, avoid extreme exertion, to return if become dyspnoeic, not to fly until at least 1 week <em>after </em>the CXR has returned to normal, and to never SCUBA dive (unless have had bilateral pleurectomies).</li></ul></li></ul><blockquote><p>Treasure T. Minimal access surgery for pneumothorax. <em>Lancet</em> 2007;370:294-5. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2807%2961136-2/fulltext" target="_blank">Reference</a>]</p><p>MacDuff A, Arnold A, Harvey J et al. Management of spontaneous pneumothorax: BTS pleural disease guideline 2010. <em>Thorax</em> 2010;65(Suppl 2):ii18-ii31.  [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20696690" target="_blank">Reference</a>] [<a
href="http://www.brit-thoracic.org.uk/" target="_blank">Website</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-spontaneous-pneumothorax/feed/</wfw:commentRss> <slash:comments>2</slash:comments> </item> <item><title>EBM Acute Asthma</title><link>http://lifeinthefastlane.com/2010/11/ebm-acute-asthma/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-acute-asthma/#comments</comments> <pubDate>Thu, 18 Nov 2010 02:00:08 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[Respiratory]]></category> <category><![CDATA[Acute Asthma]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[asthma]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27120</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-acute-asthma/">EBM Acute Asthma</a></p><p>Evidence based review of acute severe asthma including clinical recognition and management</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-acute-asthma/">EBM Acute Asthma</a></p><p><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;"> Clinical recognition of severe or critical asthma</span></h4><ul><li>Severe asthma indicated by any one of (admit<em> every</em> patient with severe):<ul><li>PEFR (or FEV<sub>I</sub>) &gt;33  50% predicted or best, or &lt; 100 L/min (or I L for FEV<sub>I</sub>).</li><li>Unable to complete sentences in one breath.</li><li>Resps  25 / min.</li><li>Pulse  120 / min (110 / min British Guideline).</li></ul></li></ul><blockquote><p>Global Initiative for Asthma (<a
href="http://www.ginasthma.org" target="_blank">GINA</a>). Global strategy for asthma management and prevention. 2009 (corrected Jan 2010). [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20477002" target="_blank">Reference</a>]</p><p>British Thoracic Society. Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. A national clinical guideline. Published May 2008, revised June 2009.  (<a
href="http://www.sign.ac.uk/pdf/sign101.pdf" target="_blank">PDF full guideline</a>) or (<a
href="http://www.sign.ac.uk/pdf/qrg101.pdf" target="_blank">PDF quick reference guide</a>).</p><p>National Heart Lung and Blood Institute. Expert Panel Report 3 (EPR 3). Guideline for the diagnosis and management of asthma. Section 5. Managing exacerbations of asthma. (<a
href="http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf" target="_blank">PDF published Aug 2007</a>).</p><p><a
href="http://www.nationalasthma.org.au/cms/index.php " target="_blank">National Asthma Council Australia</a>. <em>Asthma Management Handbook</em> 2006. (<a
href="http://www.nationalasthma.org.au/cms/index.php" target="_blank">6th edition of handbook 2006</a>).</p></blockquote><ul><li>Life-threatening or critical asthma has any one of (admit to ICU):<ul><li>PEF  33% predicted or best</li><li>Silent chest, feeble breaths, cyanosis.</li><li>Bradycardia, hypotension.</li><li>Exhaustion, confusion, coma.</li></ul></li><li>Measure ABG if SaO<sub>2 </sub> 92% on oxygen or any of the features above present, and look for PaO<sub>2</sub> 8 kPa (60 mmHg), low pH, raised PaCO<sub>2 </sub>6.0 kPa (45 mmHg), and low K<sup>+</sup>.</li><li>Note concern that long-acting beta-agonists salmeterol and formoterol with or without inhaled corticosteroids have increased risk intubation / death (OR 2.1)</li></ul><blockquote><p>Salpeter S, Wall A, Buckley N. Long-acting beta-agonists with and without inhaled  corticosteroids and catastrophic asthma events. <em>Am J Med</em> 2010;123:322-8. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20176343" target="_blank">Reference</a>] [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20408768" target="_blank">Update Reference</a>]</p><p>Holley A, Boots R. Review article: Management of acute severe and near-fatal asthma. <em>Emerg Med Australas</em> 2009;21:259-68. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/19682010" target="_blank">Reference</a>]</p></blockquote><h4><span
style="font-weight: normal;">Management of Acute Asthma</span></h4><p>[Note the American, Canadian, British, Australian and GINA guidelines all subtly <em>differ</em> in drug and dose recommendations].</p><ul><li><strong>Beta agonists</strong><ul><li>Continuous oxygen-driven salbutamol nebulisers with 5-10 mg (1-2 ml) in 2 ml saline are appropriate in unresponsive severe, or critical asthma.</li><li>Reduce to 5 mg 1-, 2-, or 3-times hourly nebs if improve. Note that there is a huge variation in respirable dose delivered by the different types of nebuliser.</li><li>Intravenous salbutamol 3-10 g/kg then 5-20 g/min (dose unknown!) reserved for non-response to above, as side effects including hypokalaemia, arrhythmias and lactic acidosis are greater IV.</li><li>IM or IV adrenaline reserved for precipitate anaphylactic asthma, or moribund asthmatic / respiratory arrest (see later).</li></ul></li><li><strong>Anticholinergic therapy</strong><ul><li>Ipratropium 500 g added to first beta agonist nebuliser and repeated once after first hour, then 4 &#8211; 6-hourly. Has additive effects with salbutamol.</li><li>Improves severe asthmatics, those not responding to salbutamol alone, and PEFR / FEV<sub>1</sub> in all, though not necessary in mild asthma.</li></ul></li></ul><blockquote><p>Stoodley RG, Aaron SD, Dales RE.  The role of ipratropium bromide in 	the emergency management of acute asthma exacerbation: a meta-analysis of randomised clinical trials.  <em>Ann Emerg Med</em> 1999; 34:8-18. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/10381989" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Corticosteroids</strong><ul><li>Wide range of doses used, but little to support “<em>more is better</em>.”</li><li>Give oral prednisone 0.5 – 1.0 mg/kg; or IV hydrocortisone 250 mg 6-hourly (British guideline considers hydrocortisone 100 mg 6-hourly as efficacious) only if vomiting / obtunded, as <em>all</em> IV steroid preparations can cause severe anaphylaxis.</li><li>Parenteral methyl prednisolone shown to improve PEFR within 1-2 hours (likely class effect).</li></ul></li></ul><blockquote><p>Krishnan J, Davis S, Naureckas E et al. An umbrella review. Corticosteroid therapy for adults with acute asthma. <em>Am J Med</em> 2009;122:977-91. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/19854321" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Magnesium</strong><ul><li>Magnesium 2g IV infusion over 20 mins <em>once</em>, if fail to improve after 1 hour of therapy. Improves PEFR and reduces admissions in severe cases in children. Adult data more limited. Note <em>potential</em> for NMJ 					blockade, hypotension and sedation in the non-ventilated patient.</li><li>Nebulised isotonic solution of magnesium sulphate in addition to beta-2 agonist improves pulmonary function in severe asthma in adults. Paeds data limited effect.</li></ul></li></ul><blockquote><p>Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. <em>Emerg Med J</em> 2007;24:823-30. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18029512" target="_blank">Reference</a>]</p><p>Blitz M et al. Inhaled magnesium sulphate in the treatment of acute asthma. <em>Cochrane Database Systemic Review</em> 2005 Oct 19. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/16235345" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Aminophylline</strong><ul><li>Reduces need for intubation in severe asthma (children), but side effects of palpitations, nausea + vomiting and tremor common. Rare use in near fatal asthma in adults. <em>Not</em> recommended.</li></ul></li></ul><blockquote><p>Parameswaran K, Belda J et al. Addition of intravenous aminophylline to beta-2 agonists in adults with acute asthma (Cochrane Review). <em>The Cochrane Library</em> 2001; Issue 3, Oxford. [Reference]</p></blockquote><ul><li><strong>Miscellaneous</strong><ul><li>CXR only for suspected consolidation, pneumothorax / pneumomediastinum, failure to respond to treatment. Not ‘routine’.</li><li>Antibiotics – only indicated if definite bacterial illness.</li><li>Fluid load – no published ‘evidence’, but necessary particularly prior to intubation when acute drop in preload is likely, or for K+ replacement 	in hypokalaemia from β2 agonists / steroids / (aminoph).</li><li>Adrenaline – if <em>in extremis</em>, give up to 5 µg/kg <em>slowly</em> IV as 1:10 000 or 1:100 000 dilution. Or give 0.3 – 0.5 mg IM for asthma in anaphylaxis.</li><li>Heliox – (helium/oxygen 80:20 or 70:30). High flow rate to increase respirable gas mass. Data mixed / not compelling + poor availability!</li></ul></li></ul><h4>Discharge Planning</h4><ul><li>Must achieve 75% of predicted or best known PEFR for at least 1-2 hours off treatment AND not have any features of a severe attack to be allowed home.</li><li><strong>Steroids</strong><ul><li>Oral prednisone for 5-7 days, stopped abruptly.</li><li>Oral prednisone for 10-14 days tapered off, if patient has a background of unstable or undertreated asthma; or has relapsed.</li></ul></li><li><strong>‘Asthma Action Plan’</strong><ul><li>Action Plan for present attack, and future episodes should be drawn up, ideally in conjunction with LMO + see NAC Australia’s website.</li></ul></li></ul><blockquote><p>Vanden Hoek T, Morrison L, Shuster M et al. Part 12: Cardiac arrest in special situations: 2010 AHA Guidelines for CPR and ECC. <em>Circulation</em> 2010;120(suppl 3):S829-S861. [<a
href="http://circ.ahajournals.org/cgi/content/full/122/18_suppl_3/S829" target="_blank">Reference</a>]</p><p>British Thoracic Society. Scottish Intercollegiate Guidelines Network. 6 Management of acute asthma. <em>Thorax</em> 2008;63(Supp IV):iv51-iv60.  [<a
href="http://www.sign.ac.uk/pdf/qrg101.pdf" target="_blank">PDF Reference</a>]</p><p>Aldington S, Beasley R. Asthma exacerbations. 5: Assessment and management of severe asthma in adults in hospital. <em>Thorax </em>2007;62:447-58. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/17468458" target="_blank">Reference</a>]</p><p>Currie G et al. Recent developments in asthma management. <em>BMJ</em> 2005;330:585-9. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/15761000" target="_blank">Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-acute-asthma/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>EBM Oesophagogastric Varices</title><link>http://lifeinthefastlane.com/2010/11/ebm-varices/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-varices/#comments</comments> <pubDate>Wed, 17 Nov 2010 02:00:14 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Gastroenterology]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[UGI varices]]></category> <category><![CDATA[varices]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27103</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-varices/">EBM Oesophagogastric Varices</a></p><p>EBM review of Oesophagogastric Varices assessment and management in the emergency department</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-varices/">EBM Oesophagogastric Varices</a></p><p><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Epidemiology</span></h4><ul><li>5-12% upper G1 bleeds.</li><li>50% cirrhosis patients have varices, up to 85% in Child-Pugh C patients.</li><li>25-35% of patients with chronic liver disease will have a variceal bleed, which accounts for 50-90% of bleeding episodes in those patients.</li><li>Mortality of a first bleed 15-30%, with rebleeding in 30-60% after banding / sclerotherapy (highest risk in first 10 days), and a 32-80% 1-year mortality.</li></ul><h4><span
style="font-weight: normal;">Management</span></h4><p><strong>Endoscopic</strong>:</p><ul><li>Banding ligation.  Lower rebleeding, mortality and complication rate than sclerotherapy.</li><li>Sclerotherapy.  Rebleed in 20-50%; higher complication rate.  May be followed by propranolol.</li><li>Tissue adhesive eg. cyanoacrylate or bucrylate especially for gastric varices; intravariceal thrombin.</li></ul><p><strong>Vasoactive drugs:</strong></p><ul><li>In absence of or awaiting (ie. during transfer); or as adjunct to (ie. octreotide) endoscopy.<ul><li>Octreotide 50 μg, then 25-50 μg/hr IV. Long-acting somatostatin analogue. 80% success with decrease in bleeding, borderline mortality benefit. Continue for 24-48 hours.</li><li>Somatostatin.  More expensive, shorter half-life.</li><li>Terlipressin (Glypressin) 2 mg 6-hrly or vasopressin +/- GTN, to reduce portal pressure and deal with coronary ischaemia.</li><li>[Beta blocker (propanolol /nadolol) +/- isosorbide. Used for primary and secondary <em>prophylaxis</em> of bleeding, but <em>not</em> in acute bleeding].</li></ul></li></ul><p><strong>Antibiotics:</strong></p><ul><li>Norfloxacin 400 mg orally bd or ciprofloxacin IV at same dose, preferably before endoscopy, in any cirrhotic patient with an upper GI bleed. Ceftriaxone 1 g IV an alternative.</li></ul><blockquote><p>Fernandez J, Ruiz del Arbor L, Gomez C et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. <em>Gastroenterology</em> 2006;131:1049-56. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/17030175" target="_blank">Reference</a>]</p></blockquote><p><strong>Balloon tamponade (Sengstaken-Blakemore tube):</strong></p><ul><li>Temporising procedure only. Up to 25% complications including death from aspiration, migration and or perforation, 50% rebleed. Need airway protection by endotracheal intubation.</li></ul><p><strong>Variceal decompression:</strong></p><ul><li>Transjugular intrahepatic portosystemic shunt (TIPS). May be preferred to surgery in refractory or rebleed patients, possibly preceded by transjugular variceal embolisation. Also when liver transplantation being considered.</li><li>Surgery. Emergency direct portacaval shunt (EPCS) or oesophageal transection.</li><li>Either technique reduces re-bleed risk and mortality, with little increase in hepatic encephalopathy risk. However, 30-day mortality up to 80%.</li></ul><blockquote><p>Scottish Intercollegiate Guidelines Network (SIGN). Management of acute upper and lower gastrointestinal haemorrhage. Sept 2008. A national clinical guideline. [<a
href="http://www.guideline.gov/content.aspx?id=13167" target="_blank">Reference</a>]</p><p>Garcia-Tsao G, Sanyal A, Grace N et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. <em>Hepatology</em> 2007;46:922-38. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/17879356" target="_blank">Reference</a>]</p><p>Gortzsche P, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. <em>Cochrane Database Syst Rev 2005; </em>CD000193. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18677774" target="_blank">Reference</a>]</p><p>Sharara A, Rockey D. Gastroesophageal variceal haemorrhage. <em>NEJM </em>2001; 345:669-681. [<a
href="http://www.nejm.org/doi/full/10.1056/NEJMra003007" target="_blank">Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-varices/feed/</wfw:commentRss> <slash:comments>2</slash:comments> </item> <item><title>EBM Upper GI Haemorrhage</title><link>http://lifeinthefastlane.com/2010/11/ebm-upper-gi-haemorrhage/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-upper-gi-haemorrhage/#comments</comments> <pubDate>Mon, 15 Nov 2010 02:00:49 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Gastroenterology]]></category> <category><![CDATA[General Surgery]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[UGI haemorrhage]]></category> <category><![CDATA[Upper GI]]></category> <category><![CDATA[Upper GI bleed]]></category> <category><![CDATA[Upper GI Haemorrhage]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27107</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-upper-gi-haemorrhage/">EBM Upper GI Haemorrhage</a></p><p>Upper GI Haemorrhage EBM Review. Commonest causes: peptic ulcer (35-50%); oesophagitis (20-30%);  duodenitis/gastritis/erosions (10-20%); varices (5-12%); Mallory-Weiss tear (2-5%); tumour (2-5%); angiodysplasia (2-3%); aorto-enteric fistula (&#60;1%).</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-upper-gi-haemorrhage/">EBM Upper GI Haemorrhage</a></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Epidemiology</span></h4><ul><li>Commonest causes: peptic ulcer (35-50%); oesophagitis (20-30%);  duodenitis/gastritis/erosions (10-20%); varices (5-12%); Mallory-Weiss tear (2-5%); tumour (2-5%); angiodysplasia (2-3%); aorto-enteric fistula (&lt;1%).</li><li>Mortality 10 &#8211; 14%. Majority are over 65 years or variceal.<ul><li>Mortality / morbidity risk factors include: cause of the bleeding particularly varices; advanced age; shock; fresh red blood; low Hb; co-morbid disease; re-bleed; endoscopic findings.</li><li>Endoscopic stigmata that predict re-bleeding, need for surgery and death include active arterial bleeding, adherent clot, non-bleeding but visible vessel, ulcer size and location. Scoring systems exists eg. Rockall (max post-endoscopy score 11); score 8 = mortality 41%.</li></ul></li><li>Low-risk group who may be managed as outpatient <em>without</em> early endoscopy can be predicted by Glasgow Blatchford score (GBS), or the pre-endoscopic Rockall score.<ul><li>GBS of 0 safely allows discharge <em>without</em> endoscopy, although up to half may then not present for OP endoscopy! Note age is not scored.</li></ul></li></ul><blockquote><p>Stanley A, Ashley D, Dalton H et al. Outpatient management of patients with low-risk upper GI haemorrhage: multicentre validation and prospective evaluation. <em>Lancet</em> 2009;373:42-7. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2808%2961769-9/fulltext" target="_blank">Reference</a>]</p></blockquote><h4><span
style="font-weight: normal;">Management</span></h4><p><strong>Medical therapy</strong></p><ul><li>Resuscitation, ABC including look for orthostatic hypotension etc. Consider transfusion for shock or acute fall in Hb below 7.0 g/dL (below 10.0 if IHD, PVD etc). Also FFP if INR &gt;1.5 and or platelets if low &lt; 50 x 10<sup>9</sup>/L.</li><li>Gastric lavage – of <em>no</em> proven benefit, but NGT may indicate ongoing bleeding.</li><li>Proton pump inhibitor by infusion ie. omeprazole / pantoprazole 80 mg stat and 8 mg/hr for 72 hours. Reduces high-risk stigmata and need for endoscopic therapy if given <em>pre</em>-endoscopy (OR 0.67). Reduces risk of rebleeding, surgery and death in high-risk patients if given <em>after</em> endoscopy (RR 0.4 / 0.43 / 0.41 respectively). Overall cost-effective and safe, and often now used routinely.</li></ul><blockquote><p>Lau J, Leung W, Wu J et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. <em>NEJM</em> 2007; 356:1631- 40. [<a
href="http://www.nejm.org/doi/full/10.1056/NEJMoa065703" target="_blank">Reference</a>]</p><p>Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. <em>Cochrane Database Syst Rev</em> 2006;1:CD002094. [2006 <a
href="http://www.ncbi.nlm.nih.gov/pubmed/16437441" target="_blank">Reference</a>] [2010 <a
href="http://www.ncbi.nlm.nih.gov/pubmed/20464720" target="_blank">Reference</a>]</p></blockquote><ul><li>H<sub>2 </sub>blocker IV. Cheap, safe but poor ability to consistently maintain a high intragastric pH &gt;6. No evidence for effect in acute bleeding.</li><li>Somatostatin or octreotide reduce rebleeding, need for transfusion and surgery, but with no improvement in mortality. Also not routine.</li></ul><p><strong>Endoscopy within first 24 hrs of admission:</strong></p><ul><li>Early endoscopy provides diagnosis, prognosis and allows immediate therapy. Reduces overall LOS. Bleeding source found in over 90%, and most (&gt;80%) will need no more than supportive therapy initially.</li><li>Otherwise may need injection therapy with adrenaline first line for active bleeding +/- other procedure such as second injectate, thermal contact, clips etc.</li><li>Other sclerosants, thrombin, tissue glue, heater probe, multipolar electrocoagulation, laser, mechanical endoclips (haemoclips) are alternatives, as adjuncts or as monotherapy.</li></ul><blockquote><p>Sung J, Tsoi K, Lai L et al. Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal haemorrhage bleeding: a meta-analysis. <em>Gut </em>2007;56:1364-73. [<a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000277/?tool=pubmed" target="_blank">Reference</a>]</p></blockquote><p><strong>Surgery / angiography</strong></p><ul><li>Surgery if endoscopy fails, and for high risk of re-bleed in the elderly.</li><li>Angiography for severe, persistent bleeding in high risk patient unsuitable for surgery.  May then use intra-arterial gelatin, springs or tissue adhesive.</li></ul><blockquote><p>Barkun A, Bardou M, Kuipers E et al. International consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding. <em>Ann Intern Med</em> 2010;152:101-13. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20083829" target="_blank">Reference</a>]</p><p>Scottish Intercollegiate Guidelines Network (SIGN). Management of acute upper and lower gastrointestinal haemorrhage. Sept 2008. A national clinical guideline. [<a
href="http://www.sign.ac.uk/pdf/sign105.pdf" target="_blank">PDF Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-upper-gi-haemorrhage/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>EBM Acute Liver Failure</title><link>http://lifeinthefastlane.com/2010/11/ebm-acute-liver-failure/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-acute-liver-failure/#comments</comments> <pubDate>Sun, 14 Nov 2010 02:00:18 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[Hepatology]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[acute liver failure]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[liver failure]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27101</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-acute-liver-failure/">EBM Acute Liver Failure</a></p><p>Acute Liver Failure in the Emergency Department an EBM Review</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-acute-liver-failure/">EBM Acute Liver Failure</a></p><p><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Definitions</span></h4><ul><li><strong>Hyperacute liver failure</strong><ul><li>Presents within 7 days of onset. 36% survival with medical management alone (single most common cause in UK and USA is paracetamol poisoning).</li></ul></li><li><strong>Acute liver failure</strong><ul><li>Encephalopathy, coagulopathy and jaundice presenting within 8-28 days in patient with previously normal liver. More likely (with hyperacute group) to get cerebral oedema (80%).</li></ul></li><li><strong>Subacute liver failure</strong><ul><li>Presents from 29-72 days, less likely to get cerebral oedema, but more likely to have ascites.  Poorer 14% survival.</li></ul></li></ul><h4><span
style="font-weight: normal;">Aetiology</span></h4><ul><li>Commonest causes (note wide geographic variation):<ul><li>Viral: hepatitis A, E (faecal-oral), B +/- D, C, EBV, CMV, HSV, HZV, parvovirus B19. Hep G, TT, SEN very rarely implicated + unclear role.</li><li>Drugs: paracetamol poisoning (single most common cause ALF in USA) – deliberate or inadvertent from multiple doses (including children), volatile anaesthetics, idiosyncratic reactions to isoniasid / rifampicin / nitrofurantoin / NSAIDs / valproate / phenytoin / statin, Ecstasy (methylmetamphetamine).</li></ul></li></ul><blockquote><p>Jalan R, Williams R, Bernuau J. Paracetamol: are therapeutic doses entirely safe? <em>Lancet</em> 2006; 368: 2195-6. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2806%2969874-7/fulltext" target="_blank">Reference</a>]</p></blockquote><ul><li>Rare (5% causes):<ul><li>Autoimmune CAH, Budd-Chiari, Wilson’s, fatty liver of pregnancy, pre-eclampsia (HELLP), mushrooms (<em>Amanita spp</em>), herbal remedies.</li><li>Malignancy, ischaemia, heat stroke, Reye’s.</li></ul></li></ul><h4><span
style="font-weight: normal;">Management</span></h4><ul><li><strong>General supportive:</strong><ul><li>Hospitalise if INR &gt;1.5; IPPV for Grade 3 or 4 coma or respiratory failure, invasive monitoring including ICP monitor (ICP &lt; 25 mmHg) +/- jugular bulb O<sub>2</sub> (NB: clinical signs / imaging unreliable to detect the earliest signs cerebral oedema), infusion 5-10% dextrose (watch for hyponatraemia), fluids and vasopressor noradrenaline therapy. GI bleeding prophylaxis.</li></ul></li><li><strong>Specific to complications: </strong><ul><li>Encephalopathy with cerebral oedema. Correct avoidable factors (hypoxia, sepsis, hyperthermia, haemorrhage, hypokalaemia, benzodiazepines), monitor ICP early. Give mannitol 0.5 g/kg if ICP ≥ 25 mmHg, or hypertonic saline 7.5% boluses 2.0 mL/kg. Moderate hypothermia 32-33<sup>O</sup>C (e.g. awaiting transplantation) being trialed.</li><li>Lactulose and neomycin appear <em>not</em> to work, and have complications such as aspiration and nephrotoxicity, respectively.</li><li>Infection. Daily surveillance for bacterial (<em>S.aureus, S.pneumoniae</em> and <em>E.coli</em>) and fungal (<em>Candida</em>) infections, including primary peritonitis.  Empiric and or prophylactic broad-spectrum antibiotics + antifungals given.</li><li>Microcirculatory / haemodynamic failure including acute oliguric renal failure. Epoprostenol (PGI<sub>2</sub>), angiotensin, vasopressors, NOS antagonists.</li><li>Coagulopathy. Vit K 10 mg IV; FFP / platelets for active bleeding; recombinant Factor VIIa (rFVIIa) with FFP – use declining + many C/Is.</li><li>N. acetylcysteine IV for paracetamol poisoning ideally within 24 hours, but even if ingested 48-72 hours before (given within 8-10 hours risk is nil to minimal).</li><li>Orthotopic liver transplantation (OLT). Note there are <em>different</em> referral criteria for paracetamol poisoning from all other causes such as INR &gt;3.0 / hypoglycaemia/ acidosis pH &lt;7.30 / encephalopathy on Day 2.<ul><li>liver unit referral shows 60-&gt;80% one year survival in selected patients. If in doubt – ring and discuss <em>early</em>…</li></ul></li><li>Liver support systems. ‘Bridging support’ to transplantation, but no conclusive evidence of benefit. Hepatocyte infusion experimental.</li></ul></li></ul><blockquote><p>Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet 2005; 365:431-3. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2805%2917832-5/fulltext" target="_blank">Reference</a>]</p><p>Bernal W, Auzinger G, Dhawan et al. Acute liver failure. <em>Lancet </em>2010;376:190-201. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960274-7/fulltext" target="_blank">Reference</a>]</p><p>Stravitz R, Kramer A, Davern T et al. Intensive care of patients with acute liver failure: Recommendations of the US Acute Liver Failure Study Group. <em>Crit Care Med</em> 2007;35:2498-2508. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/17901832" target="_blank">Reference</a>]</p></blockquote><p><strong> </strong></p><h4><span
style="font-weight: normal;">Acute on Chronic Liver Failure</span></h4><ul><li>Acute deterioration in liver function over days to weeks in patients with pre-existing chronic liver disease (CLD). Poor prognosis from underlying cirrhosis and end-stage liver disease (ESLD) with portal hypertension, ascites and 	multi-organ failure.</li><li>Much more common than ALF. Features include jaundice, coagulopathy, encephalopathy (precipitated by sepsis including spontaneous bacterial peritonitis, or GI bleed, alcohol, constipation, hypokalaemia, and drugs 	including NSAIDs and sedatives), hepatorenal syndrome and hepatopulmonary syndrome.</li></ul><blockquote><p>Macnaughtan J, Thomas H. Liver failure at the front door. <em>Clinical Medicine </em>2010;10:73-8. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20408313" target="_blank">Reference</a>]</p><p>Bailey C, Hern H. Hepatic failure: An evidence-based approach in the emergency department. <em><a
href="http://www.ebmedicine.net/" target="_blank">Emergency Medicine Practice</a></em> 2010;12(4):1-24. [<a
href="http://www.ebmedicine.net/topics.php?paction=showTopic&amp;topic_id=219" target="_blank">Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-acute-liver-failure/feed/</wfw:commentRss> <slash:comments>2</slash:comments> </item> <item><title>EBM Diabetic Ketoacidosis</title><link>http://lifeinthefastlane.com/2010/11/ebm-diabetic-ketoacidosis/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-diabetic-ketoacidosis/#comments</comments> <pubDate>Thu, 11 Nov 2010 02:00:41 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[Clinical Research]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Endocrinology]]></category> <category><![CDATA[Evidence Based Medicine]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[diabetic ketoacidosis]]></category> <category><![CDATA[DKA]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27099</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-diabetic-ketoacidosis/">EBM Diabetic Ketoacidosis</a></p><p>Review of EBM for the assessment and management of Diabetic Ketoacidosis in the emergency department</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-diabetic-ketoacidosis/">EBM Diabetic Ketoacidosis</a></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Epidemiology</span></h4><ul><li>New diagnosis of diabetes 10-27%.</li><li>Infection ~ 35%, inadequate insulin ~ 30%, surgery, trauma, alcohol, cocaine and drugs such as steroids, thiazides, sympathomimetics, pentamidine.</li><li>No cause in 19-38%, but poor compliance / economic reasons frequent.</li><li>Mortality  1% in adults, but  5% if over 65 years. Also high  15% in patients with hyperglycaemic, hyperosmolar non-ketotic syndrome (HHNS), when BSL usually &gt; 50 mmol/L, more dehydrated with osmolality is &gt; 320 mosm/L &#8211; can calculate latter by (2[NA + K] + glucose).</li></ul><h4><span
style="font-weight: normal;">Diagnostic Criteria</span></h4><ul><li>Raised glucose &gt;11.1 mmol/L</li><li>Acidosis with arterial / venous pH &lt; 7.3, or venous  bicarb &lt; 15 mmol/L</li><li>Ketonaemia or ketonuria (urinalysis may miss 3-beta hydroxybutyrate early).</li></ul><h4><span
style="font-weight: normal;">Management / Complications</span></h4><ul><li><strong>Hypoperfusion</strong><ul><li>Rapid initial crystalloid, especially for significant circulatory insufficiency, at 15-20 mL/kg in first hour ie. 1-1.5 L.</li><li><em>Possible</em> role for bicarbonate is in patients with impending cardiovascular collapse, if pH &lt; 6.9. Dilute 100 mmol 8.4%   bicarbonate in 250-1000 mL 0.45% NS, and give over 30-60 minutes with 20 mmol K via infusion pump. (Note there are <em>no</em> prospective data concerning bicarbonate use below pH 6.9, and from 6.9-7.1 morbidity and mortality outcomes are equivocal ie. not proven).</li></ul></li><li><strong>Fluid replacement</strong><ul><li>Total body water deficit 100 mL/kg, and sodium deficit 7-10 mmol/kg.</li><li>Restore normal hydration with 0.9% NS at 4-14 mL/kg/hr, to correct estimated fluid deficit over first 24 hours, without exceeding change in osmolality greater than 3 mOsm/kg per hour.</li><li>One regime is NS 1000 mL in first hour, 500 mL/hr next 4 hours, then 250 mL/hr next 4 hours ie. around 4 L in first 9 hours.</li><li>Aim to restore fluid deficits over 24 hours in adults, or up to 48 hours in children.</li></ul></li></ul><blockquote><p>Dhatariya K. Diabetic ketoacidosis. <em>BMJ</em> 2007;334:1284-5. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/17585123" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Insulin infusion</strong><ul><li>Insulin infusion at 0.1 units/kg/hr (ie. 5-7 units/hr) short-acting insulin, until BSL &lt; 15 mmol/L, then drop to 3 units/hr.</li><li>Aim is to increase venous bicarb by 3 mmol/L/hr; or to drop blood ketone level by 0.5 mmol/L/hr.</li><li>IV bolus of short-acting insulin 0.15 units/kg is unnecessary.</li></ul></li><li><strong>Hypokalaemia</strong><ul><li>Total body deficit 3-5 mmol/kg.  Give 10-30 mmol K<sup>+ </sup>per L fluid, as soon as it is known serum K<sup>+ </sup>level is below 5.0 mmol/L, and urine output is established.</li><li>Give 40 mmol per L fluid if K<sup>+</sup> &lt; 3.5 mmol/L, but <em>must</em> use infusion pump for fluid.</li></ul></li><li><strong>Hypoglycaemia</strong><ul><li>Insulin infusion will drop sugar roughly 3-5 mmol/L per hour, whilst ketones are cleared. Avoid BSL dropping below 15 mmol/L.</li><li>Change to 5-10% dextrose if BSL 15 mmol/L, and continue insulin until ketonaemia is suppressed. Bedside ketone meters now available.</li><li>If volume status is still not optimal, continue the NS together with the 10% dextrose at 125 mL/hr.</li></ul></li><li><strong>Hyperchloraemic acidosis</strong><ul><li>Usually related to fluid therapy, but is mild and transient.</li><li>Change to <sup>1</sup>/<sub>2 </sub>NS (0.45%) if Na  150 mmol/L. (Remember corrected serum Na level is higher than measured. Add 1 mmol/L to [Na] for each 3 mmol/L rise in BSL above normal).</li></ul></li><li><strong>Hypophosphataemia / hypomagnesaemia </strong><ul><li>Despite significant depletion up to 1 mmol/kg phosphate, and 1-2 mEql/kg magnesium, which may not be reflected by serum levels, replacement of either does not appear to influence clinical course or outcome.</li></ul></li><li><strong>Cerebral oedema </strong><ul><li>Suspect if sudden headache with neurological deterioration ie. altered level of consciousness and lethargy, usually within 4-12 hours treatment onset (but can occur <em>before</em> initiation of therapy).</li><li>0.7 &#8211; 1% incidence, usually child / adolescent. Mortality 25 -30% with significant neurological morbidity in 35-40%.</li><li>Cerebral vasoconstriction with hypoxic ischaemia and disease severity implicated, plus possibly idiogenic osmoles (taurine, myoinositol) and defective Na/H ion exchange.</li><li>Relates to a lower pH / (PaCO<sub>2</sub>)and higher K+ and urea at presentation, and smaller increases in serum Na<sup>+</sup>.</li><li>Also risk is increased with early (in 1<sup>st</sup> hour) insulin administration (OR 12.7) and large volumes of fluid in first 4 hours (OR 6.55), but <em>not</em> use of bicarbonate (UK case control data).</li><li>Rate of change of sugar level, and rates of fluid, sodium, or insulin delivery after first 4 hours do <em>not </em>correlate highly with cerebral oedema occurrence i.e. later therapy is <em>not</em> responsible.</li><li>Give mannitol 0.5 – 2.0 g/kg (2.5 – 10 mL/kg 20% mannitol) IV and supplemental oxygen; or consider 3% hypertonic saline 5-10 ml/kg over 30 min instead. Hyperventilation and or dexamethasone appear unhelpful.</li></ul></li></ul><blockquote><p>Edge J, Jakes R, Roy Y. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. <em>Diabetologia</em> 2006;49:2002-9. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/16847700" target="_blank">Reference</a>]</p><p>Glaser N, Barnett P et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. <em>NEJM</em> 2001; 344:264-269. [<a
href="http://www.nejm.org/doi/full/10.1056/NEJM200101253440404" target="_blank">Reference</a>] (Editorial Dunger D, Edge J. 302-303) [<a
href="http://www.nejm.org/doi/full/10.1056/NEJM200101253440412" target="_blank">Reference</a>].</p><p>Hom J, Sinert R. Is fluid therapy associated with cerebral edema in children with diabetic ketoacidosis? <em>Ann Emerg Med</em> 2008;52:69-75. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18387706" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Thromboembolism</strong><ul><li>Prophylactic low-dose heparin, especially older patients (or if hyperglycaemic, hyperosmolar non-ketotic (HHNS) syndrome).</li></ul></li></ul><blockquote><p>Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. March 2010. [<a
href="http://www.library.nhs.uk/Diabetes/ViewResource.aspx?resID=345687" target="_blank">Reference</a>]</p><p>Kitabchi A, Umpierrez G, Miles J, Fisher J. Hyperglycaemic crises in adult patients with diabetes. <em>Diabetes Care</em> 2009;32:1335-43. [<a
href="http://care.diabetesjournals.org/content/32/7/1335.full" target="_blank">Reference</a>]</p><p>Savage M, Kilvert A (on behalf of <a
href="http://www.diabetologists.org.uk/" target="_blank">Assoc British Clinical Diabetologists</a> ABCD). ABCD Guidelines for the management of hyperglycaemic emergencies in adults. <em>Practical Diabetes Int</em> 2006;23:227-31. [<a
href="http://onlinelibrary.wiley.com/doi/10.1002/pdi.957/full" target="_blank">Reference</a>]</p><p>ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. <em>Arch Dis Child</em> 2004;89:188-94 [<a
href="http://adc.bmj.com/content/89/2/188" target="_blank">Reference</a>] [or <em>Pediatrics</em> 2004; 113:e133-e140].</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-diabetic-ketoacidosis/feed/</wfw:commentRss> <slash:comments>0</slash:comments> </item> <item><title>EBM Subarachnoid Haemorrhage</title><link>http://lifeinthefastlane.com/2010/11/ebm-subarachnoid-haemorrhage/</link> <comments>http://lifeinthefastlane.com/2010/11/ebm-subarachnoid-haemorrhage/#comments</comments> <pubDate>Wed, 10 Nov 2010 02:00:52 +0000</pubDate> <dc:creator>Mike Cadogan</dc:creator> <category><![CDATA[AFTB Lecture]]></category> <category><![CDATA[EBM Lecture]]></category> <category><![CDATA[Education]]></category> <category><![CDATA[Featured]]></category> <category><![CDATA[Health]]></category> <category><![CDATA[lecture notes]]></category> <category><![CDATA[Medical Specialty]]></category> <category><![CDATA[Neurology]]></category> <category><![CDATA[Neurosurgery]]></category> <category><![CDATA[AFTB]]></category> <category><![CDATA[EBM]]></category> <category><![CDATA[FRACP]]></category> <category><![CDATA[lecture series]]></category> <category><![CDATA[SAH]]></category> <category><![CDATA[Subarachnoid Haemorrhage]]></category><guid
isPermaLink="false">http://lifeinthefastlane.com/?p=27093</guid> <description><![CDATA[<p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-subarachnoid-haemorrhage/">EBM Subarachnoid Haemorrhage</a></p><p>Review of EBM surrounding the assessment and management of Subarachnoid Haemorrhage in the emergency department</p></p><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></description> <content:encoded><![CDATA[<p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog</a> <a
href="http://lifeinthefastlane.com/2010/11/ebm-subarachnoid-haemorrhage/">EBM Subarachnoid Haemorrhage</a></p><p><script src="http://tilt.tripdatabase.com/scripts/refer.js" type="text/javascript"></script></p><blockquote><p>Pedagogical disambiguation: <a
href="http://lifeinthefastlane.com/education/lecture-notes/" target="_self">Emergency Medicine Lecture Notes</a> and Evidence Based  emergency medicine principles from <a
title="Prof Anthony Brown" href="http://lifeinthefastlane.com/2008/12/professor-tony-brown/" target="_self">Professor A.F.T Brown</a> and the Life in the Fast Lane team.</p></blockquote><h4><span
style="font-weight: normal;">Headache</span></h4><ul><li><strong>Life threatening Causes</strong><ul><li><a
title="EBM Meningitis" href="http://lifeinthefastlane.com/2010/11/ebm-meningitis/" target="_blank">Meningitis</a></li><li>Subarachnoid haemorrhage</li><li>Space occupying lesion</li><li>Hypertensive encephalopathy</li><li>Temporal arteritis (age over 50; ESR &gt; 50)</li><li>Pre-eclampsia</li></ul></li></ul><p><strong>The majority of cases however are:</strong></p><ul><li><a
href="http://lifeinthefastlane.com/2010/11/ebm-migraine/" target="_self">Migraine</a>: common or classical</li><li>Tension-type headache</li><li>Post-traumatic headache</li><li>Disease in other cranial structures eg. glaucoma, iritis, sinusitis, otitis, TMJ dysfunction.</li></ul><h4><span
style="font-weight: normal;">Subarachnoid Haemorrhage</span></h4><ul><li>5% of all acute strokes, but 25% of the fatalities, as case fatality rate around 50% overall (10-20% pre-hospital). 20-30% survivors have residual disability, epilepsy in 7-12% and 50% ‘good’ outcomes have neuropsychological and cognitive impairment.</li><li>Initially misdiagnosed in 20% as ‘migraine’ or ‘tension-headache’ on first encounter, as headache can abate or disappear. Up to 15% re-bleed early, and 40% in next 4 weeks, although risk is highest in those with large aneurysms / in poor condition.</li></ul><h4><span
style="font-weight: normal;">Clinical Features</span></h4><ul><li>Typical Presentation<ul><li><em>Sudden</em>, instantaneous onset, maximum within minutes “<em>worst headache ever”</em>; generalised and unrelenting. Associated vomiting, neck pain, meningismus, altered mental status (&gt;60%), and localising neurological signs incl III N with PCA aneurysm.  May collapse (syncopal episode) then recover.</li><li>Overall one in 100 headache patients seen in ED will have SAH, and up to 10% of those with a severe, abrupt-onset headache</li></ul></li><li><strong>Atypical presentations</strong>:<ul><li>Low grade fever, neck or back pain, seizures (7%), coma (up to 30%), focal stroke, restlessness, confusion or delirium.</li></ul></li></ul><blockquote><p>Kowalski R, Claassen J, Kreiter K et al. Initial misdiagnosis and outcome after subarachnoid haemorrhage. <em>JAMA </em>2004; 291: 866 -9. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/14970066" target="_blank">Reference</a>]</p></blockquote><p><strong>Investigations</strong></p><ul><li><strong>CT scan</strong> (thin &lt; 3 mm cuts without contrast)<ul><li>First line investigation. Over 95% &#8211; 98% sensitivity in first 12 hrs, 93% by 24 hrs, but drops to 50% by day 7.</li><li>May indicate site of bleed, early complications eg. hydrocephalus and cerebral oedema, or an alternative diagnosis.</li></ul></li><li><strong>Angiography</strong><ul><li>CT angiography (CTA) sensitivity for aneurysm 97.9%.</li><li>Negative CT followed by negative CTA will give post-test probability of <em>excluding</em> SAH of 99.43%. But note up to 2% population may have an ‘incidental’ small aneurysm.</li><li>Digital subtraction angiography (DSA) traditional gold standard, but is invasive. Or possibly proceed to MRA particularly for suspected partial thrombosis or spinal cord / brain stem origin.</li></ul></li></ul><blockquote><p>McCormack R, Hutson A. Can CTA of the brain replace LP in the evaluation of acute-onset headache after a negative noncontrast cranial CT? <em>Acad Emerg Med </em>2010;17:444-51. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/20370785" target="_blank">Reference</a>]</p></blockquote><ul><li><strong>Lumbar Puncture (LP)</strong><ul><li>If CT is negative, though see CT/CTA combination NPV 99.43% above.</li><li>Check for xanthochromia by spectrophotometry of spun CSF, shielded from light.</li><li>Perform LP 12 hours post headache to <em>most</em> reliably differentiate from a traumatic tap (absence of xanthochromia and bilirubin). Minimum 6 hrs.</li><li>Note complications of LP include failure, equivocal result (15-20%), post-LP headache (up to 40%), low back pain, local infection or traumatic neurology, and traumatic tap with difficulty in interpretation.</li></ul></li></ul><blockquote><p>Boesiger B, Shiber J. Subarachnoid hemorrhage diagnosis by computed tomography and lumbar puncture: are fifth generation CT scanners better at identifying subarachnoid hemorrhage? <em>J Emerg Med</em> 2005; 29:23-7. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/15961003" target="_blank">Reference</a>]</p><p>Schwartz D. Feedback: Computed tomography and lumbar puncture for the diagnosis of subarachnoid haemorrhage: The importance of accurate interpretation. <em>Ann Emerg Med</em> 2002; 39: 190-2. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/11823775" target="_blank">Reference</a>]</p></blockquote><p><strong> </strong></p><h4><span
style="font-weight: normal;">Management</span></h4><ul><li>Airway, oxygen, analgesia, hydration, blood pressure control and ICU care including for possible hydrocephalus, pulmonary oedema, arrhythmias, hyponatraemia etc. Newer interest in statins, magnesium and neuroprotective agents.</li><li>Nimodipine 60 mg po 4-hrly upon confirmation of diagnosis if BP stable. Consider 1 mg/h IV increased to 2 mg/h after 2 hours if comatose.<ul><li>Reduces vasospasm by up to 50% and delayed ischaemic deficit by up to 60%, by vasodilating and protecting against reperfusion injury from calcium influx.</li></ul></li><li>Endovascular platinum coils (GDCs) preferred first line management within first 72 hours, espec posterior circulation.</li><li>Alternative is early surgery clipping if patient presents within 2-3 days of onset, particularly if large neck to aneurysm.  Or may be delayed up to 14 days if spasm and infarction occur.</li></ul><blockquote><p>Ferro J, Canhão P, Peralta R. Update on subarachnoid haemorrhage. <em>J Neurol</em> 2008;255:465-79. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18357424" target="_blank">Reference</a>]</p><p>Edlow J, Malek A, Ogilvy C. Aneurysmal subarachnoid haemorrhage: update for emergency physicians. <em>J Emerg Med</em> 2008;34:237-51. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/18155383" target="_blank">Reference</a>]</p><p>van Gijn J, Kerr R, Rinkel G. Subarachnoid haemorrhage. <em>Lancet</em> 2007; 369: 306-318. [<a
href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2807%2960153-6/fulltext" target="_blank">Reference</a>]</p><p>Al-Shahi R, White P, Davenport R et al. Subarachnoid haemorrhage. <em>BMJ</em> 2006; 333:235-40. [<a
href="http://www.ncbi.nlm.nih.gov/pubmed/16873858" target="_blank">Reference</a>]</p><p>Suarez J, Tarr R, Selman W. Aneurysmal subarachnoid hemorrhage. <em>N Eng J Med </em>2006; 354:387-96. [<a
href="http://www.nejm.org/doi/full/10.1056/NEJMra052732" target="_blank">Reference</a>]</p></blockquote><p><a
href="http://lifeinthefastlane.com">Life in the Fast Lane Medical Blog - Emergency Medicine education blog</a></p>]]></content:encoded> <wfw:commentRss>http://lifeinthefastlane.com/2010/11/ebm-subarachnoid-haemorrhage/feed/</wfw:commentRss> <slash:comments>2</slash:comments> </item> </channel> </rss>
<!-- Served from: lifeinthefastlane.com @ 2012-05-25 01:37:31 by W3 Total Cache -->
